Page last updated: 2024-08-26

arsenic and Cancer of Liver

arsenic has been researched along with Cancer of Liver in 197 studies

Research

Studies (197)

TimeframeStudies, this research(%)All Research%
pre-199037 (18.78)18.7374
1990's10 (5.08)18.2507
2000's55 (27.92)29.6817
2010's80 (40.61)24.3611
2020's15 (7.61)2.80

Authors

AuthorsStudies
Ali, M; Bhardwaj, SK; Chaudhary, A; Haque, R; Khan, A; Sinha, KK; Srivastava, A1
Cheng, M; Li, B; Li, F; Piao, JG; Sun, J; Wei, Y; Ye, T; Zheng, H; Zhou, M1
Aki, T; Funakoshi, T; Kukita, M; Takata, M; Uemura, K; Unuma, K1
Dongbin, X; Hulai, W; Jing, S; Jingke, Z; Xiaoxia, X; Yanying, Z; Yonggang, T1
Gu, SY; Li, Y; Zhang, ZZ1
Doi, K; Fujioka, M; Gi, M; Kakehashi, A; Okuno, T; Wanibuchi, H; Yamaguchi, T1
Fang, L; Huang, P; Islam, K; Liu, YJ; Naranmandura, H; Wang, C; Yang, C; Zhang, H; Zhang, YH; Zhang, YW; Zheng, XW1
Du, P; Lu, W; Yang, C; Zhang, JC; Zhang, JL1
Fu, Y; Guo, BB; Jiang, HY; Li, S; Liu, LY; Wang, KK; Wu, CJ; Zhang, CM; Zhang, F; Zhang, Y1
Chen, CF; Chern, CL; Ho, CT; Lin, LC; Liu, JJ; Liu, TZ1
Hai, Y; Li, H; Li, Y; Ma, W; Song, P; Wang, X; Wu, Z; Xie, Q; Zhao, L1
Ali, M; Ali, V; Bimal, S; Haque, R; Kumar, N; Sadaf, N1
Ji, S; Li, W; Wang, L; Wang, M; Zhang, C; Zhang, J1
Fujioka, M; Kakehashi, A; Kato, M; Kitano, M; Tago, Y; Wanibuchi, H; Wei, M; Yamada, T; Yamano, S1
Ao, JY; Bu, Y; Chai, ZT; Kong, LQ; Lu, L; Sun, HC; Tang, ZY; Zhang, KZ; Zhang, QB; Zhang, YY; Zhu, XD1
Jiang, F; Li, Y; Li, Z; Mu, J; Ning, S; Si, L; Wang, X; Ye, X1
Fang, ZT; Li, S; Liu, R; Qian, S; Qu, XD; Wang, GZ; Wang, JH; Wang, LL; Yang, GW; Yang, MJ; Zhang, W; Zhang, WS; Zhu, L1
Fan, Z; Huaqun, F; Kai, W; Kaiyang, W; Linquan, W; Mingwen, H; Xiangbao, Y; Xin, Y1
Chen, X; Jiang, H; Li, Y; Liang, Y; Liu, J; Liu, L; Lu, Z; Meng, X; Pan, S; Qi, S; Song, X; Sun, B; Wang, J; Xie, C; Yin, D; Zheng, T1
Akrami, SM; Habibi, L; Karimi, A; Madjd, Z1
Fu, HQ; Huang, MW; Wang, K; Wang, KY; Wu, LQ; Yin, XB; Yu, X; Zhou, F1
Liu, F; Wang, W; Wei, J; Ye, C1
Jiang, F; Li, Y; Li, Z; Liu, Q; Shen, J; Wang, X; Zhang, J1
Jiang, F; Li, Y; Li, Z; Liu, Q; Lu, X; Shen, J; Wang, X; Zhang, J1
Chen, CZ; Hu, YN; Jiang, XJ; Zhang, ZZ; Zhao, W1
He, C; Jiang, H; Jiang, X; Ma, L; Sun, X; Xu, L; Zhai, B; Zhao, D1
Ling, S; Sun, D; Tian, Y; Wang, L; Yang, X1
Deng, J; Li, Y; Luo, Q; Zhang, Z1
He, X; Hu, BS; Huang, JW; Li, Y; Liu, B; Lu, LG; Zhao, W; Zheng, YB1
Deng, JJ; Li, Y; Luo, QY; Zhang, ZZ1
Lai, Y; Li, Y; Luo, Q; Zhang, Z1
Jin, G; Liu, D; Liu, Y; Sun, Z; Wang, C; Wang, H; Wang, X; Yu, S; Zhang, B1
Gao, B; Lu, M; Meng, X; Miao, Z; Qiao, X; Wu, L; Xue, D; Zhang, W1
Cao, Y; Fan, J; He, YF; Hu, B; Huang, XW; Qiu, SJ; Sun, C; Sun, YF; Wang, Z; Yang, XR; Zeng, HY; Zhang, X; Zhou, J1
Nohara, K; Suzuki, T1
Cao, Z; Chen, X; Cui, L; Gao, B; Zhang, S; Zhang, W1
Chi, X; Gao, J; Liu, H; Shan, H; Zhang, Z; Zhao, Z; Zhou, H; Zhu, X1
Chen, C; Hu, H; Li, H1
Chen, FY; Gu, ZJ; Kulkarni, P; Li, JQ; Li, L; Liu, L; Mason, RP; Tang, BB; Tang, Q; Yi, JW1
Gu, SY; Hu, YN; Zhang, ZZ1
Chen, M; Cheng, X; Fan, X; Ji, J; Song, J; Wu, F; Ying, X; Zhang, D; Zhao, Z1
Chang, Y; Jiang, M; Zhou, Q; Zhou, R; Zhu, C1
Fan, L; Liang, K; Liang, W; Peng, G; Wang, L; Wang, R; Xu, Y; Ye, Q1
Chen, P; Cui, P; Duan, Z; Gao, Q; Li, H; Li, Y; Song, P; Wang, A; Wang, D; Wang, X; Wang, Y; Wu, Z; Zhao, L; Zhu, R; Zhu, S1
Fei, W; Han, S; Li, F; Tao, J; Wang, X; Wei, Y; Zhang, Y; Zheng, H; Zhu, J1
Gao, F; Liu, Y; Song, W1
Lou, Z; Shen, L; Xu, G; Zhang, G1
Lv, XH; Wang, CH; Xie, Y1
Cheng, C; Cui, X; Fei, M; Gao, S; He, S; Ke, Q; Li, P; Liu, Y; Lu, M; Shen, A; Wang, Y; Zhao, Y1
Aklilu, M; Kindler, HL; Nattam, S; Vokes, EE1
Cao, EH; Liang, XQ; Liu, XM; Song, Y; Tang, RJ; Xiong, XF1
Kita, K; Ochi, T; Sato, M; Suzuki, T1
Chen, X; Liu, LX; Zhang, M1
Song, J; Wang, ZY; Zhang, DS1
Abbadessa, G; Blaszkowsky, LS; Chen, H; Costa, M; Feun, L; Gold, P; Henderson, C; Hochster, H; Lewis, J; Muggia, F; Nierodzik, M; Rosenzweig, B; Ryan, T; Van Veldhuizen, P; Wu, J; Zheng, H; Zhu, AX1
Jiang, HC; Liu, TF; Song, PL; Sun, B; Zhao, XS1
Chen, X; Jiang, H; Krissansen, GW; Ma, Y; Pan, S; Sun, B; Sun, X1
Chen, X; Jiang, H; Liu, L; Ma, Y; Pan, S; Sun, X; Wang, J; Zhu, H1
Chen, X; Jiang, HC; Liu, LX; Meng, XZ; Pan, SH; Wang, JB; Zhang, WH; Zheng, TS1
Chang, YJ; Cheng, YW; Chiou, JF; Hsieh, PY; Hsu, CH; Ko, HL; Liu, TZ; Ting, LL; Tung, JN; Wu, AT1
Han, H; Jiang, T; Lu, H; Luo, R; Shen, P1
Chen, BA; Liu, L; Qin, SK1
Gu, N; Li, GZ; Lu, Q; Niu, HZ; Teng, GJ; Wang, ZY; Xu, RZ; Yu, H; Zhang, DS; Zhu, GY1
Chen, C; Huang, D; Qi, Y; Wang, Y; Xi, Y; Zhang, Y1
Hua, H; Li, J; Qin, S; Rui, J1
Hong, DY; Huang, HS; Liu, ZM; Tseng, JT1
Acalovschi, M; Aldea, M; Fischer-Fodor, E; Irimie, A; Kacso, G; Mosteanu, O; Petrushev, B; Pop, T; Soritau, O; Susman, S; Tomuleasa, C1
Bian, J; Guo, J; Wang, Y; Wu, H; Wu, X; Zhang, C; Zhang, S; Zhou, J1
Chen, G; Chen, JX; Hua, ZC; Tang, B; Wang, K; Yang, BY1
Dumitrescu, LS; Fischer-Fodor, E; Hey-Hawkins, E; Lönnecke, P; Mikláš, R; Miklášová, N; Schrepler, MP; Tomuleasa, CI; Virag, P1
Chen, Q; Hao, XZ; Liu, JW; Qin, SK; Qu, FL; Qu, T; Sui, GJ; Sun, Y; Zhang, HP1
Diwan, BA; Thomas, DJ; Tokar, EJ; Waalkes, MP1
Jia, S; Yang, S; Yang, T; Yang, Y; Zhang, X1
Allensworth, JL; Devi, GR; Diehl, AM; Lyerly, HK; Morse, MA; Rangwala, F; Smith, GR; Thomas, Z; Williams, KP1
Cao, LM; Li, HY1
Cheng, HT; Guo, CY; Hu, HT; Li, HL; Luo, JP; Meng, YL; Xiao, JC; Yao, QJ1
Chen, CX; Huang, FL; Wang, HN; Wang, YL1
Allain, N; Fardel, O; Guillouzo, A; Le Vée, M; Morel, F; Vernhet, L1
Liu, JW; Shen, Y; Tang, Y; Zhong, XY1
Chen, GQ; Chen, Z; Jing, Y; Styblo, M; Walton, F; Waxman, S; Weinberg, R; Zhou, L1
Hong, L; Qi, QH; Wang, SS; Wang, XL; Zhang, T1
Wang, ZH; Yu, D; Zhu, LY1
JHAVERI, SS1
Akao, Y; Futatsugawa, S; Kito, M; Matsumoto, K; Naoe, T; Nozawa, Y; Sera, K; Wada, N1
Dorsey, WC; Tchounwou, PB; Yedjou, CG1
Li, JT; Ou, QJ; Wu, YC1
Ahmed, M; Gazelle, GS; Goldberg, SN; Horkan, C; Kruskal, JB; Liu, Z; Solazzo, SA1
Chen, H; Hua, HQ; Qin, SK; Wang, JH1
Chen, W; Guo, HX; Jiang, HC; Liu, LX; Liu, ZH; Wang, XQ; Wu, M; Zhang, TD; Zhu, AL1
Dong, X; Jiang, H; Kanwar, JR; Krissansen, GW; Luo, L; Meng, F; Qiao, H; Sun, X; Zhou, B1
Cui, X; Hatakeyama, K; Hirano, S; Shirai, Y; Wakai, T; Yokoyama, N1
Fu, Q; Hu, BR; Li, JJ; Li, Y; Ming, ZY; Qian, JQ; Tang, Q; Xiang, JZ1
Cheng, AL; Hsu, C; Hsu, CH; Hsu, WL; Lin, CC; Yang, CH1
Kumar, R; Mukhopadhyay, AK; Paul, MK1
Cui, XP; Li, P; Lu, MD; Shen, AG; Wang, Y1
Chen, Q; Gao, P; Jin, H; Tian, C; Wang, X; Yue, W; Zheng, Y1
Cui, YZ; Luo, RC; Wu, J; Zhang, H1
Calmus, Y; Poupon, R1
Mendelow, H; Pataki, KI; Roat, JW; Wald, A1
Eichner, D; Gottschalk, D; Gottschalk, I; Norpoth, K; Schmidt, EH; Thomas, H; Witting, U1
Bruguera, M; Castells, A; Forns, X; Navasa, M; Rodés, J; Salgado, M; Sans, M1
Gottesman, MM; Pastan, I; Shen, D1
Busteros, JI; Dueñas, C; López-Morante, A; Martin-Lorente, JL; Pérez-Alvarez, JC; Sáez-Royuela, F; Yuguero, L1
Chen, H; Liu, L; Liu, W; Ma, J; Qin, S; Wang, J1
Ishaque, AB; Schneider, J; Tchounwou, PB; Wilson, BA1
Chen, Y; He, Z; Liu, X; Qian, J; Qin, S; Shao, Z; Wang, L1
He, Z; Qian, J; Qin, S1
Akao, Y; Kito, M; Nozawa, Y; Ohishi, N; Yagi, K1
Chan, JY; Fung, KP; Siu, KP1
Chabner, BA; Doroshow, JH; Locker, GY; Zwelling, LA1
Berk, PD; Creech, J; Falk, H; Martin, JF; Popper, H; Selikoff, IJ; Thomas, L; Watanabe, P; Young, RS1
Nyfors, A; Sogaard, H; Zachariae, H1
Grinnell, F; Shere, PA1
Galt, RM; Knock, FE; Oester, YT; Sylvester, R1
Khan, H; Rana, SVS; Verma, Y1
Chen, H; Chen, J; Chen, X; Chen, Z; Huang, Y; Li, D; Su, Z; Wang, H1
Deng, M; Gao, M; Guo, G; Han, J; Huang, H; Huang, J; Huang, X; Jing, J; Kloeber, JA; Liu, S; Lou, Z; Qi, Z; Xu, M; Xu, Z1
Acharya, PB; Kuppusamy Selvam, M; Mukherjee, A; Singh, A1
Nohara, K; Okamura, K; Sato, M; Suzuki, T1
Chen, J; Gu, J; Guo, J; Hu, X; Li, D; Li, X; Liu, J; Mei, C; Peng, C; Xiao, Y; Zhang, K; Zhang, X; Zhou, B1
Cao, H; Liu, Q; Sun, J; Wu, L; Wu, M1
Fischer, F; Gunesch, S; Hartwig, A; Lumpp, T; Schumacher, P; Stößer, S1
El-Serag, HB; Olayode, A; Oluyomi, AO; Roy, H; Symanski, E; Thrift, AP1
Abbasnezhad, A; Abd El-Ghafar, OA; Abhilash, L; Abouzid, KAM; Achberger, AM; Ackerman, S; Akhatayeva, Z; Akin, D; Al-Kaysi, RO; Alakhdar, AA; Alame, M; Aleksic Sabo, V; Alinezhadbalalami, N; Allen, JD; Alonso, JM; Alqatani, S; Alsayed, B; Álvarez Larraondo, M; Alvarez, M; Amini, SB; An, Z; Anasir, MI; Anderson, GH; Andremont, A; Andrés, S; Angel, S; Anigboro, AA; Anini, Y; Antonides, CFJ; Arafa, K; Arafa, RK; Aryal, UK; Asbaghi, O; Assefa, MK; Atyah, M; Avwioroko, OJ; Ayora-Talavera, G; Azpilikueta, A; Azyazov, VN; Ba, YF; Bachmann, KF; Badoual, J; Bae, SJ; Baek, SH; Bahrami, B; Bai, J; Baid-Agrawal, S; Bailey, MR; Baillie, JK; Balani, N; Balcar, VJ; Banica, T; Banks, L; Barb, J; Bardeen, CJ; Barrett, HE; Bartnikowski, N; Bashir, R; Battaglia, M; Bautista-Hernández, V; Becker, B; Beekman, FJ; Benidir, M; Benjelloun, M; Bentley, RF; Bergé, J; Berger, D; Bernsen, MR; Berraondo, P; Bhattacharya, R; Bhayani, SB; Bi, W; Bi, X; Bi, YL; Bi, Z; Bian, K; Biesecker, LG; Billadeau, DD; Blaszczyk, R; Blum, JL; Boachie, R; Boelte, K; Bogers, AJJC; Boileau, I; Bonduelle, C; Bonny, O; Bonsu, JM; Boos, LA; Borges-Argáez, R; Bouchard, PA; Boudot, C; Bourgeade-Delmas, S; Boutet-Robinet, E; Boyle, AJ; Branigan, D; Briones, S; Broniowska, KA; Brossas, JY; Brown, WA; Brzezinska, J; Buitron, G; Burnier, M; Bursulaya, B; Burton, PR; Bush, AA; Busuttil, RW; Cabello-Aguilar, S; Cáceres-Farfán, M; Cacheux, V; Caffrey, PJ; Cai, B; Cai, Q; Cai, S; Cai, Y; Calders, P; Cammarota, G; Campbell, DA; Cancelli, C; Cao, Q; Cao, WH; Cao, X; Capet, M; Capoluongo, E; Carey, ME; Carnero, M; Carrasco, LI; Carreno, J; Carrillo-Reyes, J; Casini, I; Cassar, M; Catalan, G; Cattamanchi, A; Cazares-Granillo, M; Celie, B; Cen, YK; Cena, H; Cerbo, RM; Ceron, E; Cetina-Montejo, L; Chaâbane-Banaoues, R; Chabanet, C; Chace-Donahue, F; Chalfun-Júnior, A; Chan-Balan, R; Chang, CS; Chen, CS; Chen, D; Chen, J; Chen, L; Chen, PN; Chen, Q; Chen, S; Chen, W; Chen, WP; Chen, X; Chen, Z; Cheng, H; Cheng, J; Cheng, Q; Cheng, T; Chi, T; Chianelli, D; Chieppa, M; Child, CJ; Cho, JH; Cho, JY; Chogtu, B; Choi, GH; Choi, J; Choi, M; Choi, NG; Cholu, CO; Chow, ES; Chowdhury, AH; Chu, PC; Chu, Q; Chu, S; Chua, H; Chung, T; Chunyan, L; Church, JS; Civardi, E; Cobiella, J; Colinge, J; Collado, CJ; Collins, TJ; Cong, LM; Conkrite, KL; Cope, SJ; Corbett, JA; Cornet, M; Cornillot, E; Corvaisier, S; Costes-Martineau, V; Courtioux, B; Coussens, M; Covino, M; Criado, A; Cui, J; Cui, Y; Cunitz, BW; Curry, AE; Cussó, L; D'Urzo, AD; D'Urzo, KA; Dabbous, S; Dahlgren, RA; Dai, H; Dai, T; Dai, W; Dalinghaus, M; Dang, S; Davalos, RV; Davidson, H; de Andrea, CE; De Angelis, M; de Blois, E; de Carvalho, PA; De Clercq, E; De Giuseppe, R; de Jong, M; De Langhe, S; De Oliveira, L; de Souza Pinto Lemgruber, R; de Souza, LB; de Swart, J; De Wandele, I; de Woestijne, PCV; Delaney, S; Delorme, M; Delvenne, P; Deng, L; Deng, Z; Denkinger, CM; der Meulen, MHV; Deraeve, C; Desco, M; DeSilva, S; Destere, A; Dhali, A; Di Ciano, P; Dias-Santagata, D; Diskin, SJ; Djè, MK; Doddipatla, S; Doerr, AJ; Dokla, EME; Domiciano, D; Domingo, N; Dong, C; Dong, J; Dong, Q; Dong, S; Dong, X; Dong, Z; Douair, I; Douglas, TA; Doyle, SM; Drain, PK; Du, K; Du, L; Du, Q; Du, S; Duan, C; Duan, H; Duan, J; Duan, S; Duan, W; Dueluzeau, R; Dukic, L; Dunmire, BL; Duvauchelle, T; Dymek, B; Dzwonek, K; Earnest, A; Eckardt, KU; El Ghadraoui, L; El Massoudi, S; Elloumi, F; Elnour, IE; Embarak, S; Ende, M; England, K; Enikeev, D; Enyedy, I; Epple, R; Erickson, GE; Eriksson, J; Erndt-Marino, J; Errachidi, F; Etxeberria, I; Evan, AP; Fairlamb, AH; Falahi, E; Fan, CC; Fan, H; Fan, M; Fan, MZ; Fan, S; Fan, Y; Fang, CS; Fang, J; Fang, X; Fang, Z; Farmany, A; Farooqi, A; Farouk, HO; Fazelipour, S; Feng, D; Feng, J; Feng, JX; Feng, YL; Ferraz, SL; Ferreira, CR; Figenshau, RS; Finn, AV; Fiseha, T; Fleischer, AS; Fogleman, AD; Fontaine, O; Ford, CR; Fouladvand, F; Four, M; Fousteri, G; Francis, JR; Fraser, JF; Frazier, RP; Fu, H; Fu, P; Fu, YJ; Fujishima, A; Fuster, V; Gabilan, JC; Gagliani, N; Gai, QY; Galán-Arriola, C; Gale, P; Galimova, GR; Galkin, A; Gallo, A; Gallo, AA; Gang, DD; Ganschow, S; Gao, C; Gao, F; Gao, GP; Gao, H; Gao, K; Gao, M; Gao, MY; Gao, P; Gao, R; Gao, S; Gao, WJ; Gao, Y; Garbacz, P; García Ruiz, L; Garcia, EM; Garofoli, F; Gasbarrini, A; Gattinoni, L; Gaudig, M; Gbureck, U; Ge, X; Genko, N; Gentile, GL; George, MW; Gerety, GF; Gestwicki, JE; Geusens, PP; Ghassemi, M; Giardina, JD; Giebultowicz, JM; Gifford, CA; Gijsen, FJH; Gilfillan, R; Gilson, E; Gingl, K; Giuliano, C; Glybochko, P; Goessler, W; Gofflot, S; Golab, J; Goldstein, A; Golebiowski, A; Gómez, L; Gómez-Carballo, J; Gonçalves, PEO; Gonzales, R; Gonzalez-Cotto, M; González-Fernández, D; Gonzalez-Lopez de Turiso, F; Goodman, JM; Govinda Raju, S; Grimm, J; Gross, AJ; Gruenheid, S; Gu, C; Gu, FF; Gu, S; Gu, Z; Guest, RL; Gui, C; Gui, J; Guillem, A; Guo, G; Guo, L; Guo, Q; Guo, S; Guo, SW; Guo, W; Guo, Y; Guo, YG; Guo, Z; Guretzky, JA; Haenggi, M; Hahn, MS; Hakkola, J; Halim, AA; Hampel, D; Han, B; Han, BH; Han, D; Han, G; Han, J; Han, LZ; Han, R; Han, S; Han, X; Han, Z; Handley, MA; Hanke, I; Hannongbua, S; Hao, P; Happ, JT; Hara, M; Haraux, F; Hare, JL; Harper, JD; Hartley, AM; Harvey, E; Hashimoto, K; Hassan, HM; Hautajärvi, H; Hayton, TW; He, C; He, H; He, HJ; He, WP; He, Y; He, Z; Hedrick, V; Heffernan, JK; Hegrová, J; Heidarimoghadam, R; Helms, K; Hengphasatporn, K; Henry, D; Herrmann, TRW; Hesson, T; Himmelbauer, MK; Hindle, A; Hoffmann, R; Hogg, N; Hong, KB; Hong, SK; Honjol, Y; Hood, C; Hsi, RS; Hsu, JL; Hu, B; Hu, BC; Hu, D; Hu, H; Hu, J; Hu, K; Hu, M; Hu, MK; Hu, T; Hu, W; Hu, Y; Hu, Z; Hua, S; Huang, H; Huang, J; Huang, L; Huang, M; Huang, P; Huang, X; Huang, Y; Huang, Z; Hukkanen, J; Hung, MC; Huo, X; Hyötyläinen, T; Ianiro, G; Ibanez, B; Imran, M; Ireland, S; Irwin, MS; Ishiguro, H; Jackowski, K; Jackson, C; Jacob, SI; Jahromy, MH; Jakob, SM; Jang, J; Javvaji, PK; Jefferson, KK; Jena, P; Ji, H; Jiang, F; Jiang, GH; Jiang, H; Jiang, J; Jiang, X; Jiang, Z; Jiao, J; Jiménez, A; Jin, X; Jincai, W; Jintao, X; Jo, K; Jofra, T; Johari, Y; Johnson, ACM; Jones, JH; Josephine Fauci, A; Juhl, AK; Jun, S; Kaiser, RI; Kajioka, J; Kajiyama, H; Kalliyil, A; Kalthur, SG; Kamalanathan, M; Kamaldinov, T; Kanaani, L; Kang, D; Kang, J; Kang, S; Känsäkoski, P; Kaplan, DL; Karwan, M; Kasibhatla, S; Kaur, A; Kawazoe, Y; Ke, C; Keyser, J; Khalique, A; Khan, IT; Kharshoum, RM; Kher, R; Kherani, J; Ki, KK; Kikkawa, F; Kikkawa, R; Kim, BT; Kim, EH; Kim, GA; Kim, GD; Kim, HB; Kim, HG; Kim, JS; Kim, MJ; Kim, SI; Kim, SJ; Kim, Y; King, K; Kinyamu-Akunda, J; Kirkkala, T; Kjaer-Sorensen, K; Kleppinger, EL; Kloner, RA; Klopfenstein, TJ; Knappe, D; Knezevic, P; Kobos, LM; Kohli, M; Kolano, L; Kolodgie, FD; Kolte, AP; Koneru, B; Kong, D; Kong, F; Kong, X; Konggidinata, MI; Köpke, M; Koski, KG; Kotsis, F; Köttgen, A; Kouakou-Kouamé, CA; Kraemer, US; Krane, V; Krehbiel, CR; Krenning, BJ; Kretzschmar, D; Ku, KB; Kubota, Y; Kulich, P; Kumar, NG; Kupiec-Weglinski, JW; Lalani, SS; Lan, X; Landfeldt, E; Langenberg, E; Lapauw, B; Larkin, J; Lassoued, MA; Laukhtina, E; Laura Martinez, J; Laveillé, A; Lavela, P; Law, AD; Lazraq, A; Le Foll, B; Lee, BK; Lee, C; Lee, CS; Lee, EJ; Lee, EY; Lee, G; Lee, HY; Lee, JH; Lee, JJ; Lee, JO; Lee, JS; Lee, R; Lei, H; Lei, P; Lellouche, F; Lennerz, JK; Leong, W; Leslie, I; Lessem, E; Levin, M; Levinger, I; Li, C; Li, CW; Li, CX; Li, CY; Li, D; Li, H; Li, HM; Li, J; Li, L; Li, LM; Li, N; Li, S; Li, W; Li, X; Li, XX; Li, Y; Li, Z; Li, ZL; Li, ZX; Lian, Q; Liang, C; Liang, GH; Liang, H; Liang, J; Liang, X; Liao, CX; Liao, R; Ličbinský, R; Lim, YS; Lima, HK; Lin, JG; Lin, L; Lin, S; Lin, WP; Lin, Z; Liso, M; Liu, BX; Liu, C; Liu, H; Liu, J; Liu, M; Liu, Q; Liu, S; Liu, SF; Liu, SL; Liu, T; Liu, W; Liu, X; Liu, XB; Liu, Y; Liu, YY; Liu, Z; Liu, ZQ; Lobo, M; Loitzenbauer, M; López, F; Lopez, G; López, GJ; Lou, Z; Lu, IC; Lu, J; Lu, M; Lu, W; Lu, X; Lu, Y; Luhovyy, BL; Luna-Abanto, J; Luo, J; Luo, K; Luo, L; Luo, M; Luo, W; Luo, X; Luo, XM; Lv, Y; Lv, YQ; Lyu, HD; Lyu, J; Ma, C; Ma, G; Ma, L; Ma, Q; Ma, X; Ma, Y; Macha, SJ; MacLean, E; Mahalapbutr, P; Maina, T; Malfait, F; Malfertheiner, MV; Malzert-Fréon, A; Mansouri, E; Mao, C; Marcellin, E; Marchiori, PER; Marcotte, DJ; Maréchal, A; Maric, N; Maris, JM; Maron, L; Marti, CN; Martínez-Milla, J; Mateo, J; Mather, K; Mathison, CJN; Matthay, MA; Maxwell, CL; Mazier, D; Mazumder, D; Mazurkiewicz, M; Mazzucchelli, TG; McAuley, DF; Mccoy, K; McVicar, DW; Mebel, AM; Mech, A; Meester, EJ; Meiselbach, H; Melero, I; Ménard, G; Meng, X; Mengya, Y; Merle, G; Meunier, B; Mfarrej, B; Mi, K; Migueliz, I; Mikuška, P; Miladi, K; Miletich, R; Millar, JE; Mills, MR; Milne, R; Minute, L; Misiak, M; Mo, F; Modi, A; Mok, F; Molina, C; Mollen, CJ; Molteni, V; Montalto, M; Montet, D; Monti, MC; Moor, MB; Moravec, P; Morsiani, C; Murillo, E; Murugan, P; Muslem, R; Myers, RK; N'guessan, FK; Nabil, H; Nadal, J; Nadeem, M; Nafady, MM; Nafie, MS; Nair, HP; Nakano, R; Nance, J; Naren, N; Neil, CJ; Nelson, J; Nery, FC; Netsch, C; Nguyen, TH; Ni, L; Ni, YX; Nie, W; Nielsen, LK; Nigam, K; Nikolayev, AA; Nishiyama, M; Niu, LL; Niu, PP; Nock, BA; Noer, PR; Noll, G; Noll, S; Norenberg, JP; Nowicka, J; Nutho, B; O'Connor, M; Obonyo, NG; Ochiai, T; Ochoa, MC; Oh, BL; Oh, S; Olczak, J; Olivares, X; Ommurugan, B; Oosthuizen, MC; Operario, D; Orešič, M; Oshima, K; Otano, I; Ou, Y; Owen, TW; Oxvig, C; Pacey, V; Pai, M; Paik, H; Paiva, R; Palmieri, EM; Palpant, N; Pan, L; Pan, Q; Panahi, S; Pang, B; Pang, ZC; Pannecouque, C; Paris, L; Park, D; Park, DJ; Park, E; Park, EC; Park, IH; Park, JH; Park, JI; Park, S; Passmore, MR; Pattaranggoon, NC; Paun, M; Pedersen, S; Pedron, J; Peng, M; Peng, X; Penzhorn, BL; Pérez-Camargo, D; Perez-Maldonado, R; Pérez-Vicente, C; Pham, TD; Pickering, L; Pickersgill, NA; Pinault, E; Pinotsis, N; Plan, M; Pocino, K; Poh, CL; Pons, EDC; Popoff, MR; Porri, D; Pourmand, A; Pratviel, G; Prudente, DO; Qi, H; Qi, N; Qian, LY; Qiao, L; Qiao, Q; Qin, QP; Qiu, N; Qiu, SW; Qu, F; Quan, M; Quigg, A; Raee, E; Raibaud, P; Ramanitrahasimbola, D; Rapoport, L; Rasby, RJ; Rasoanirina, BNV; Raspini, B; Ratner, JR; Razafindrakoto, Z; Redd, MA; Ren, H; Ren, N; Rey, J; Reynolds, CP; Rich, PR; Richards, CJ; Rigol, M; Rimoldi, S; Robert, P; Rodrigues, AE; Roe, JH; Rohde, S; Rokita, JL; Roland, J; Rombaut, L; Ronkainen, J; Rothenberg, SM; Roy, SC; Ruan, Z; Rucker, PV; Rueda, D; Ruhwald, M; Rungrotmongkol, T; Rupert, AS; Rusjan, P; Ryabov, AD; Rysä, J; Saad, NES; Sabioni, P; Sadow, PM; Sahai, N; Salem, HF; Salinas, B; Salonurmi, T; Samé Guerra, D; Sánchez, J; Sanchez-González, J; Sanmamed, MF; Sansores-Peraza, P; Santoro, JC; Santschi, PH; Saritas, T; Sarkisova, Y; Savolainen, MJ; Scherberich, JE; Schlom, DG; Schmelz, EM; Schmid, MC; Schneider, MP; Schumacher, S; Schwartz, JC; Schwartzer, JJ; Schwehr, K; Schweitzer, DH; Scott, ME; Sedky, NK; See Hoe, L; Sejian, V; Selvaraju, S; Sen, SK; Seo, G; Šerý, O; Settles, JA; Sfar, S; Shaffer, J; Shan, GL; Shang, Q; Shannahan, JH; Shao, B; Shao, H; Shao, J; Shao, ZH; Shasha, Y; Shaw, K; Sheeba, V; Shekar, K; Shen, G; Shen, H; Shen, XD; Shen, Y; Sherrell, PC; Shete, PB; Shi, AX; Shi, J; Shi, JH; Shi, S; Shi, X; Shigeta, Y; Shimbo, A; Shin, E; Sikka, N; Silhavy, TJ; Simanon, N; Simard, S; Simon, J; Simon, M; Simpson, SD; Simundic, AM; Since, M; Singh, B; Singhroy, DN; Sinisterra, OT; Smith, EH; Sobreira, TJP; Solanes, N; Somasundar, Y; Sommerer, C; Sonei, A; Song, B; Song, E; Song, J; Song, M; Song, Y; Soo Lee, M; Sorensen, MD; Sournia-Saquet, A; Spaepen, E; Spirk, D; Srivastava, S; Stancill, JS; Stanczak, PS; Starenki, D; Starr, F; Step, DL; Steubl, D; Stigliani, JL; Stráská, J; Sträter, N; Su, ZZ; Sudano, I; Suen, JY; Suh, HJ; Sui, ZY; Suico, JG; Suleiman, K; Sumon, K; Sun, HB; Sun, J; Sun, L; Sun, LL; Sun, M; Sun, Q; Sun, W; Sun, X; Sun, XF; Sun, Y; Sun, YB; Sun, YH; Sun, YN; Sun, Z; Sunada, K; Suzuki, S; Sylvan, JB; Takala, J; Talla, D; Tamir, Z; Tan, SJ; Tanda, S; Tang, H; Tang, J; Tang, LF; Tang, SJ; Tang, Y; Tao, FB; Tappel, R; Taratkin, M; Teijeira, Á; Tellew, JE; Thomas, AM; Thomas, SG; Thomson, SR; Tian, J; Tie, Y; Tirado, JL; Tolonen, A; Tosato, G; Tronnet, A; Tsai, S; Turtoi, A; Turtoi, E; Tvrdoňová, M; Tyagi, A; Tzou, DT; Uddin Ahmad, Z; Urias, E; Usawachintachit, M; Ustriyana, P; Utsumi, F; Vacca, M; Vaculovič, T; Vaidya, SS; Valentin, A; Valgepea, K; van den Berg, P; van den Bergh, JP; van der Heiden, K; van Gaalen, K; Van Gemert, W; van Haard, PMM; van Hest, JCM; Vecchiarelli, E; Večeřa, Z; Venkatesh, R; Verhaeghe, P; Verhagen, HJ; Vetter, JM; Vieira, D; Vilchez-Tschischke, JP; Villena-Gutierrez, R; Villoslada Terrones, V; Vital-Jacome, M; Voelkl, J; Vogel, K; Vogrin, S; Volke, D; von Bahr, V; Vysloužil, J; Wade, TL; Wagner-Gillespie, M; Walsh, SW; Wan, LJ; Wan, SP; Wang, AL; Wang, B; Wang, BY; Wang, C; Wang, D; Wang, F; Wang, H; Wang, HR; Wang, HY; Wang, J; Wang, JY; Wang, K; Wang, L; Wang, LF; Wang, P; Wang, Q; Wang, R; Wang, SF; Wang, SP; Wang, SR; Wang, T; Wang, W; Wang, WP; Wang, X; Wang, XJ; Wang, Y; Wang, YL; Wang, YN; Wáng, YXJ; Wang, Z; Wang, ZF; Wang, ZY; Waning, B; Warner, JM; Washington, SL; Watson, AK; Wei, B; Wei, C; Wei, F; Wei, X; Wei, Y; Wemhoff, AP; Wen, Z; Weng, TT; Wesdemiotis, C; Wheeler, DA; Wildner, M; Wilson, BK; Wirth, LJ; Wissler, M; Wu, F; Wu, G; Wu, J; Wu, KH; Wu, MC; Wu, P; Wu, PK; Wu, S; Wu, W; Wu, X; Wu, XP; Wu, Y; Wyatt, E; Wyllie, S; Xia, Y; Xiao, BH; Xiao, SZ; Xiao, W; Xiao, X; Xiao, Z; Xie, D; Xie, K; Xie, X; Xie, Y; Xie, YF; Xin, S; Xin, Z; Xing, Q; Xing, WQ; Xiong, D; Xiong, X; Xu, C; Xu, D; Xu, F; Xu, G; Xu, H; Xu, J; Xu, JY; Xu, L; Xu, N; Xu, W; Xu, X; Xu, Y; Xu, YM; Xue, H; Xue, J; Xue, Z; Yan, R; Yan, SQ; Yan, W; Yan, X; Yan, Z; Yang, C; Yang, D; Yang, F; Yang, FC; Yang, G; Yang, J; Yang, M; Yang, P; Yang, Q; Yang, R; Yang, S; Yang, SJ; Yang, TWW; Yang, X; Yang, Y; Yang, Z; Yao, C; Yao, L; Yao, LP; Yao, M; Yao, T; Yao, W; Yao, Y; Yaseen, T; Yazdani, V; Ye, J; Ye, S; Yerys, BE; Yi, HWL; Yi, JL; Yin, F; Yin, J; Yin, Y; Yin, Z; Yong, ZP; Yongli, S; Yoo, JS; Yoshikawa, N; You, Q; Yu, B; Yu, CQ; Yu, H; Yu, HG; Yu, J; Yu, L; Yu, Q; Yu, X; Yu, Y; Yu, YK; Yu, Z; Yuan, Q; Yuan, R; Yuan, W; Yuan, X; Yuan, Y; Zager, RA; Zagozdzon, A; Zaller, N; Zang, YP; Zappi, ME; Zelikoff, JT; Zeman, T; Zhai, X; Zhan, P; Zhang, B; Zhang, C; Zhang, G; Zhang, H; Zhang, HB; Zhang, J; Zhang, JS; Zhang, L; Zhang, M; Zhang, Q; Zhang, RX; Zhang, S; Zhang, T; Zhang, W; Zhang, WH; Zhang, X; Zhang, XX; Zhang, Y; Zhang, YQ; Zhang, YW; Zhang, Z; Zhang, ZH; Zhao, D; Zhao, FL; Zhao, K; Zhao, L; Zhao, M; Zhao, R; Zhao, S; Zhao, W; Zhao, WG; Zhao, X; Zhao, Y; Zheng, G; Zheng, J; Zheng, S; Zheng, W; Zheng, Y; Zheng, YG; Zhong, Z; Zhou, C; Zhou, D; Zhou, H; Zhou, HY; Zhou, L; Zhou, Q; Zhou, X; Zhou, Y; Zhou, YL; Zhou, Z; Zhu, J; Zhu, L; Zhu, N; Zhu, X; Zhu, XF; Zhu, Y; Zhu, Z1
Cui, H; Deng, H; Deng, J; Deng, Y; Hu, Y; Ren, Z; Tang, W; Wu, Q; Xu, SY; Yu, S; Zuo, Z1
Jin, Z; Wu, P; Yan, G; Yang, J; Yi, X; Zhou, M1
Jiang, W; Liu, S; Nurmamat, H; Shen, Z; Wu, B; Wu, J; Yu, Y1
Nohara, K; Okamura, K; Suzuki, T; Takumi, S1
Cheng, S; Wang, W; Zhang, D1
Biondi, A; Costa, C; Costanzo, V; Fago, L; Fenga, C; Ferrante, M; Fuccio Sanzà, G; Ledda, C; Loreto, C; Marconi, A; Matera, S; Palmucci, S; Pomara, C; Rapisarda, V; Zammit, C1
Choiniere, J; Wang, L; Wu, J1
Liu, J; Waalkes, MP1
Ferreccio, C; Liaw, J; Marshall, G; Smith, AH; Steinmaus, C; Yuan, Y1
Bortner, C; Liu, J; Sifre, MI; Sun, Y; Tokar, EJ; Waalkes, MP; Yu, L1
Lai, R; Li, X; Wang, Y; Yu, RA1
Kim, EY; Kim, HJ; Kim, TH; Park, CS; Park, YS; Shin, JH; Song, HY1
Hirano, S; Kobayashi, Y; Mizumura, A; Watanabe, T1
Afridi, HI; Baig, JA; Chandio, AA; Kandhro, GA; Kazi, TG; Khan, S; Kolachi, NF; Nasreen, S; Shah, AQ; Wadhwa, SK1
Callegari, E; Elamin, BK; Gramantieri, L; Negrini, M; Sabbioni, S1
Chang, HT; Guo, HR; Huang, NC; Lin, SL; Wang, JS; Wann, SR1
Diwan, BA; Tokar, EJ; Waalkes, MP1
Chen, CY; Guo, HR; Hung, TL; Sung, TI; Wang, YJ1
Afridi, HI; Kazi, NG; Kazi, TG; Khan, S; Kolachi, NF1
Afridi, HI; Arain, SS; Kazi, NG; Kazi, TG; Kolachi, NF1
Chen, CY; Guo, HR; Lin, HJ; Sung, TI1
Centeno, JA; Gibb, H; Ladich, ER; Longfellow, D; Martinez, L; Mullick, FG; Page, NP; Thompson, C1
ROTH, F1
Diwan, BA; Liu, J; Waalkes, MP; Ward, JM; Xie, Y1
Ahsan, H; Chen, Y1
Chiu, HF; Ho, SC; Wang, LY; Wu, TN; Yang, CY1
Yu, MC; Yuan, JM1
Kim, SG; Lee, CH; Park, JW1
Li, L; Liu, Z; Shi, H; Sun, H; Wu, W1
Collins, J; Diwan, BA; Ducharme, DM; Liu, J; Logsdon, D; Merrick, BA; Shen, J; Waalkes, MP; Xie, Y1
Diwan, BA; Ducharme, DM; Grissom, SF; Liu, J; Merrick, BA; Paules, RS; Shen, J; Tennant, R; Tucker, CJ; Waalkes, MP; Xie, Y1
Diwan, BA; Liu, J; Waalkes, MP; Ward, JM1
Atmaca, M; Fry, JR; Gottschalg, E; Kind, CN; Moore, NE; Pratt, S; Ryan, AK; Travis, LC; Waller, RC1
Benbrahim-Tallaa, L; Boos, J; Liu, J; Qian, X; Qu, W; Waalkes, MP; Xie, Y; Yu, L1
Begum, RA; Farah, IO; Ishaque, AB1
Arnold, W; Bleese, N1
Kasper, ML; Schoenfield, L; Strom, RL; Theologides, A1
Rakovic, M1
Balázs, L; Barna, K; Kádas, I; Pár, A2
Lüchtrath, H1
Caldwell, GG; Falk, H; Ishak, KG; Popper, H; Thomas, LB1
Brady, JA; Cardamone, AT; Vianna, NJ1
Edmonds, L; Falk, H; Heath, CW; Herbert, JT; Popper, H; Thomas, LB1
Vianna, NJ1
Ghai, GL; Prunés, L; Zaldívar, R1
Brown, KG; Chen, CJ1
Luo, FJ; Luo, ZD; Ma, L1
Biggs, ML; Hopenhayn-Rich, C; Smith, AH1
Chen, CJ; Kuo, TL; Morales, KH; Ryan, L; Wu, MM1
Cheng, ML; LeCluyse, EL; Liu, J; Lu, T; Waalkes, MP; Zhou, YS1
Alpert, M1
Aposhian, HV; Chen, ML; Liu, J; Waalkes, MP; Zhang, A; Zheng, B; Zhou, Y1
Popper, H1
Cowen, AE; Cowlishaw, JL; Pollard, EJ; Powell, LW1
Malchow, H; Schmeisser, W1
Gerber, MA; Popper, H; Schaffner, F; Selikoff, IJ1
Falk, H; Popper, H; Selikoff, IJ; Telles, NC; Thomas, LB1
Alrenga, DP1
Aach, RD; Boswell, DC; Lander, JJ; Stanley, RJ; Sumner, HW1
Bates, MN; Duggan, HM; Goeden, HM; Hertz-Picciotto, I; Hopenhayn-Rich, C; Kosnett, MJ; Smith, AH; Smith, MT; Wood, R1
Chen, CJ; Chen, CW; Kuo, TL; Wu, MM1
Fujita, H; Kappas, A; Mitani, K; Sassa, S1
De Groote, J; Desmet, V; Fevery, J; Nevens, F; Sciot, R; Van Steenbergen, W1
Antoniello, L; Cohen, H; Fosman, E; Rodríguez, J; Rondán, M1
Philipp, R1
Nigam, VN1
Arcos, JC; Mathison, JB; Mouledoux, AM; Tison, MJ1
Grinnell, F; Milam, M; Srere, PA1
Carmack, C; Geokas, MC; Haverback, BJ; Rinderknecht, H1
Holland, JF; Kim, U; Ospina, J; Regelson, W1
Kanisawa, M; Schroeder, HA1

Reviews

24 review(s) available for arsenic and Cancer of Liver

ArticleYear
Nanocarrier-based delivery of arsenic trioxide for hepatocellular carcinoma therapy.
    Nanomedicine (London, England), 2022, Volume: 17, Issue:26

    Topics: Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Carcinoma, Hepatocellular; Cell Line, Tumor; Humans; Liver Neoplasms; Oxides

2022
Arsenic trioxide combined with transarterial chemoembolization for unresectable primary hepatic carcinoma: A systematic review and meta-analysis.
    Medicine, 2018, Volume: 97, Issue:18

    Topics: Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Combined Modality Therapy; Humans; Liver Neoplasms; Oxides; Quality of Life; Survival Rate; Treatment Outcome

2018
[Exploration of Epigenetic Changes and DNA Methylation Markers Associated with Liver Tumors Induced by Inorganic Arsenite Exposure in Mice].
    Nihon eiseigaku zasshi. Japanese journal of hygiene, 2015, Volume: 70, Issue:3

    Topics: Animals; Arsenicals; DNA Methylation; Epigenesis, Genetic; Female; Gene Expression; Histone Code; Humans; Liver Neoplasms; Maternal Exposure; Maternal-Fetal Exchange; Mice, Inbred C3H; Pregnancy; Proto-Oncogene Proteins c-fos

2015
Arsenic trioxide combined with transarterial chemoembolization for primary liver cancer: A meta-analysis.
    Journal of gastroenterology and hepatology, 2017, Volume: 32, Issue:9

    Topics: Adult; Aged; Aged, 80 and over; Arsenic Trioxide; Arsenicals; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Chemotherapy, Adjuvant; Cholangiocarcinoma; Databases, Bibliographic; Female; Humans; Infusions, Intra-Arterial; Infusions, Intravenous; Liver Neoplasms; Male; Middle Aged; Oxides; Randomized Controlled Trials as Topic; Treatment Outcome; Young Adult

2017
[The liver and arsenic].
    Gastroenterologie clinique et biologique, 1982, Volume: 6, Issue:11

    Topics: Animals; Arsenic; Arsenic Poisoning; Arsenicals; Chemical and Drug Induced Liver Injury; Hemangiosarcoma; Humans; Hypertension, Portal; Liver; Liver Cirrhosis; Liver Diseases; Liver Neoplasms

1982
[Hepatic angiosarcoma: a report of a case associated with treatment with arsenic salts and a review of the literature].
    Gastroenterologia y hepatologia, 1995, Volume: 18, Issue:3

    Topics: Arsenicals; Arsphenamine; Biopsy; Fatal Outcome; Hemangiosarcoma; Hemoperitoneum; Humans; Liver; Liver Neoplasms; Male; Middle Aged; Shock; Syphilis; Time Factors

1995
Idiopathic portal hypertension and angiosarcoma associated with arsenical salts therapy.
    Journal of clinical gastroenterology, 1998, Volume: 26, Issue:4

    Topics: Arsenicals; Hemangiosarcoma; Humans; Hypertension, Portal; Liver Neoplasms; Male; Middle Aged; Psoriasis

1998
The clinical features of hepatic angiosarcoma: a report of four cases and a review of the English literature.
    Medicine, 1979, Volume: 58, Issue:1

    Topics: Adult; Aged; Antineoplastic Agents; Arsenicals; Doxorubicin; Female; Hemangiosarcoma; Hemochromatosis; Hepatectomy; Humans; Liver; Liver Diseases; Liver Neoplasms; Male; Middle Aged; Prognosis; Radium; Thorium Dioxide; Vinyl Chloride

1979
Non-coding RNA therapeutics: Towards a new candidate for arsenic-induced liver disease.
    Chemico-biological interactions, 2023, Sep-01, Volume: 382

    Topics: Arsenic; Biomarkers; Carcinoma, Hepatocellular; Humans; Liver Neoplasms; MicroRNAs; RNA, Long Noncoding; RNA, Untranslated

2023
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor Proteins, Signal Transducing; Adenine; Adenocarcinoma; Adipogenesis; Administration, Cutaneous; Administration, Ophthalmic; Adolescent; Adsorption; Adult; Aeromonas hydrophila; Aerosols; Aged; Aged, 80 and over; Aging; Agriculture; Air Pollutants; Air Pollution; Airway Remodeling; Alanine Transaminase; Albuminuria; Aldehyde Dehydrogenase 1 Family; Algorithms; AlkB Homolog 2, Alpha-Ketoglutarate-Dependent Dioxygenase; Alzheimer Disease; Amino Acid Sequence; Ammonia; Ammonium Compounds; Anaerobiosis; Anesthetics, Dissociative; Anesthetics, Inhalation; Animals; Anti-Bacterial Agents; Anti-HIV Agents; Anti-Infective Agents; Anti-Inflammatory Agents; Antibiotics, Antineoplastic; Antibodies, Antineutrophil Cytoplasmic; Antibodies, Monoclonal, Humanized; Antifungal Agents; Antigens, Bacterial; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antitubercular Agents; Antiviral Agents; Apolipoproteins E; Apoptosis; Arabidopsis; Arabidopsis Proteins; Arsenic; Arthritis, Rheumatoid; Asthma; Atherosclerosis; ATP-Dependent Proteases; Attitude of Health Personnel; Australia; Austria; Autophagy; Axitinib; Bacteria; Bacterial Outer Membrane Proteins; Bacterial Proteins; Bacterial Toxins; Bacterial Typing Techniques; Bariatric Surgery; Base Composition; Bayes Theorem; Benzoxazoles; Benzylamines; beta Catenin; Betacoronavirus; Betula; Binding Sites; Biological Availability; Biological Oxygen Demand Analysis; Biomarkers; Biomarkers, Tumor; Biopsy; Bioreactors; Biosensing Techniques; Birth Weight; Blindness; Blood Chemical Analysis; Blood Gas Analysis; Blood Glucose; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Blood-Brain Barrier; Blotting, Western; Body Mass Index; Body Weight; Bone and Bones; Bone Density; Bone Resorption; Borates; Brain; Brain Infarction; Brain Injuries, Traumatic; Brain Neoplasms; Breakfast; Breast Milk Expression; Breast Neoplasms; Bronchi; Bronchoalveolar Lavage Fluid; Buffaloes; Cadherins; Calcification, Physiologic; Calcium Compounds; Calcium, Dietary; Cannula; Caprolactam; Carbon; Carbon Dioxide; Carboplatin; Carcinogenesis; Carcinoma, Ductal; Carcinoma, Ehrlich Tumor; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Pancreatic Ductal; Carcinoma, Renal Cell; Cardiovascular Diseases; Carps; Carrageenan; Case-Control Studies; Catalysis; Catalytic Domain; Cattle; CD8-Positive T-Lymphocytes; Cell Adhesion; Cell Cycle Proteins; Cell Death; Cell Differentiation; Cell Line; Cell Line, Tumor; Cell Movement; Cell Nucleus; Cell Phone Use; Cell Proliferation; Cell Survival; Cell Transformation, Neoplastic; Cell Transformation, Viral; Cells, Cultured; Cellulose; Chemical Phenomena; Chemoradiotherapy; Child; Child Development; Child, Preschool; China; Chitosan; Chlorocebus aethiops; Cholecalciferol; Chromatography, Liquid; Circadian Clocks; Circadian Rhythm; Circular Dichroism; Cisplatin; Citric Acid; Clinical Competence; Clinical Laboratory Techniques; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Clostridioides difficile; Clostridium Infections; Coculture Techniques; Cohort Studies; Cold Temperature; Colitis; Collagen Type I; Collagen Type I, alpha 1 Chain; Collagen Type XI; Color; Connective Tissue Diseases; Copper; Coronary Angiography; Coronavirus 3C Proteases; Coronavirus Infections; Cost of Illness; Counselors; COVID-19; COVID-19 Testing; Creatine Kinase; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Cryoelectron Microscopy; Cryosurgery; Crystallography, X-Ray; Cues; Cultural Competency; Cultural Diversity; Curriculum; Cyclic AMP Response Element-Binding Protein; Cyclin-Dependent Kinase Inhibitor p21; Cycloparaffins; Cysteine Endopeptidases; Cytokines; Cytoplasm; Cytoprotection; Databases, Factual; Denitrification; Deoxycytidine; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diagnosis, Differential; Diatoms; Diet; Diet, High-Fat; Dietary Exposure; Diffusion Magnetic Resonance Imaging; Diketopiperazines; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Disease Models, Animal; Disease Progression; Disease-Free Survival; DNA; DNA Damage; DNA Glycosylases; DNA Repair; DNA-Binding Proteins; DNA, Bacterial; DNA, Viral; Docetaxel; Dose Fractionation, Radiation; Dose-Response Relationship, Drug; Down-Regulation; Doxorubicin; Drosophila; Drosophila melanogaster; Drug Carriers; Drug Delivery Systems; Drug Liberation; Drug Repositioning; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Drug Synergism; Drug Therapy, Combination; Edema; Edible Grain; Education, Graduate; Education, Medical, Graduate; Education, Pharmacy; Ehlers-Danlos Syndrome; Electron Transport Complex III; Electron Transport Complex IV; Electronic Nicotine Delivery Systems; Emergency Service, Hospital; Empathy; Emulsions; Endothelial Cells; Endurance Training; Energy Intake; Enterovirus A, Human; Environment; Environmental Monitoring; Enzyme Assays; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Epoxide Hydrolases; Epoxy Compounds; Erythrocyte Count; Erythrocytes; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Esophagectomy; Estrogens; Etanercept; Ethiopia; Ethnicity; Ethylenes; Exanthema; Exercise; Exercise Test; Exercise Tolerance; Extracellular Matrix; Extracorporeal Membrane Oxygenation; Eye Infections, Fungal; False Negative Reactions; Fatty Acids; Fecal Microbiota Transplantation; Feces; Female; Femur Neck; Fermentation; Ferritins; Fetal Development; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Fibroblasts; Fibroins; Fish Proteins; Flavanones; Flavonoids; Focus Groups; Follow-Up Studies; Food Handling; Food Supply; Food, Formulated; Forced Expiratory Volume; Forests; Fractures, Bone; Fruit and Vegetable Juices; Fusobacteria; G1 Phase Cell Cycle Checkpoints; G2 Phase Cell Cycle Checkpoints; Gamma Rays; Gastrectomy; Gastrointestinal Microbiome; Gastrointestinal Stromal Tumors; Gefitinib; Gels; Gemcitabine; Gene Amplification; Gene Expression; Gene Expression Regulation; Gene Expression Regulation, Bacterial; Gene Expression Regulation, Neoplastic; Gene Expression Regulation, Plant; Gene Knockdown Techniques; Gene-Environment Interaction; Genotype; Germany; Glioma; Glomerular Filtration Rate; Glucagon; Glucocorticoids; Glycemic Control; Glycerol; Glycogen Synthase Kinase 3 beta; Glycolipids; Glycolysis; Goblet Cells; Gram-Negative Bacterial Infections; Granulocyte Colony-Stimulating Factor; Graphite; Greenhouse Effect; Guanidines; Haemophilus influenzae; HCT116 Cells; Health Knowledge, Attitudes, Practice; Health Personnel; Health Services Accessibility; Health Services Needs and Demand; Health Status Disparities; Healthy Volunteers; Heart Failure; Heart Rate; Heart Transplantation; Heart-Assist Devices; HEK293 Cells; Heme; Heme Oxygenase-1; Hemolysis; Hemorrhage; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Hepatocytes; Hexoses; High-Throughput Nucleotide Sequencing; Hippo Signaling Pathway; Histamine; Histamine Agonists; Histidine; Histone Deacetylase 2; HIV Infections; HIV Reverse Transcriptase; HIV-1; Homebound Persons; Homeodomain Proteins; Homosexuality, Male; Hospice and Palliative Care Nursing; HSP70 Heat-Shock Proteins; Humans; Hyaluronan Receptors; Hydrogen; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrolysis; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypoglycemia; Hypoglycemic Agents; Hypoxia; Idiopathic Interstitial Pneumonias; Imaging, Three-Dimensional; Imatinib Mesylate; Immunotherapy; Implementation Science; Incidence; INDEL Mutation; Induced Pluripotent Stem Cells; Industrial Waste; Infant; Infant, Newborn; Inflammation; Inflammation Mediators; Infliximab; Infusions, Intravenous; Inhibitory Concentration 50; Injections; Insecticides; Insulin-Like Growth Factor Binding Protein 5; Insulin-Secreting Cells; Interleukin-1; Interleukin-17; Interleukin-8; Internship and Residency; Intestines; Intracellular Signaling Peptides and Proteins; Ion Transport; Iridaceae; Iridoid Glucosides; Islets of Langerhans Transplantation; Isodon; Isoflurane; Isotopes; Italy; Joint Instability; Ketamine; Kidney; Kidney Failure, Chronic; Kidney Function Tests; Kidney Neoplasms; Kinetics; Klebsiella pneumoniae; Knee Joint; Kruppel-Like Factor 4; Kruppel-Like Transcription Factors; Lactate Dehydrogenase 5; Laparoscopy; Laser Therapy; Lasers, Semiconductor; Lasers, Solid-State; Laurates; Lead; Leukocyte L1 Antigen Complex; Leukocytes, Mononuclear; Light; Lipid Peroxidation; Lipopolysaccharides; Liposomes; Liver; Liver Cirrhosis; Liver Neoplasms; Liver Transplantation; Locomotion; Longitudinal Studies; Lopinavir; Lower Urinary Tract Symptoms; Lubricants; Lung; Lung Diseases, Interstitial; Lung Neoplasms; Lymphocyte Activation; Lymphocytes, Tumor-Infiltrating; Lymphoma, Mantle-Cell; Lysosomes; Macrophages; Male; Manganese Compounds; MAP Kinase Kinase 4; Mass Screening; Maternal Health; Medicine, Chinese Traditional; Melanoma, Experimental; Memantine; Membrane Glycoproteins; Membrane Proteins; Mesenchymal Stem Cell Transplantation; Metal Nanoparticles; Metalloendopeptidases; Metalloporphyrins; Methadone; Methane; Methicillin-Resistant Staphylococcus aureus; Mexico; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Inbred ICR; Mice, Knockout; Mice, Nude; Mice, SCID; Mice, Transgenic; Microarray Analysis; Microbial Sensitivity Tests; Microbiota; Micronutrients; MicroRNAs; Microscopy, Confocal; Microsomes, Liver; Middle Aged; Milk; Milk, Human; Minority Groups; Mitochondria; Mitochondrial Membranes; Mitochondrial Proteins; Models, Animal; Models, Molecular; Molecular Conformation; Molecular Docking Simulation; Molecular Dynamics Simulation; Molecular Epidemiology; Molecular Structure; Molecular Weight; Multilocus Sequence Typing; Multimodal Imaging; Muscle Strength; Muscle, Skeletal; Muscular Diseases; Mutation; Mycobacterium tuberculosis; Myocardial Stunning; Myristates; NAD(P)H Dehydrogenase (Quinone); Nanocomposites; Nanogels; Nanoparticles; Nanotechnology; Naphthalenes; Nasal Cavity; National Health Programs; Necrosis; Needs Assessment; Neoadjuvant Therapy; Neonicotinoids; Neoplasm Invasiveness; Neoplasm Metastasis; Neoplasm Proteins; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasm Transplantation; Neoplasms; Neoplastic Stem Cells; Netherlands; Neuroblastoma; Neuroprotective Agents; Neutrophils; NF-kappa B; NFATC Transcription Factors; Nicotiana; Nicotine; Nitrates; Nitrification; Nitrites; Nitro Compounds; Nitrogen; Nitrogen Dioxide; North Carolina; Nuclear Magnetic Resonance, Biomolecular; Nuclear Proteins; Nucleic Acid Hybridization; Nucleosomes; Nutrients; Obesity; Obesity, Morbid; Oceans and Seas; Oncogene Protein v-akt; Oncogenes; Oocytes; Open Reading Frames; Osteoclasts; Osteogenesis; Osteoporosis; Osteoporosis, Postmenopausal; Outpatients; Ovarian Neoplasms; Ovariectomy; Overweight; Oxazines; Oxidants; Oxidation-Reduction; Oxidative Stress; Oxides; Oxidoreductases; Oxygen; Oxygen Inhalation Therapy; Oxygenators, Membrane; Ozone; Paclitaxel; Paenibacillus; Pain Measurement; Palliative Care; Pancreatic Neoplasms; Pandemics; Parasympathetic Nervous System; Particulate Matter; Pasteurization; Patient Preference; Patient Satisfaction; Pediatric Obesity; Permeability; Peroxiredoxins; Peroxynitrous Acid; Pharmaceutical Services; Pharmacists; Pharmacy; Phaseolus; Phenotype; Phoeniceae; Phosphates; Phosphatidylinositol 3-Kinases; Phospholipid Transfer Proteins; Phospholipids; Phosphorus; Phosphorylation; Photoperiod; Photosynthesis; Phylogeny; Physical Endurance; Physicians; Pilot Projects; Piperidines; Pituitary Adenylate Cyclase-Activating Polypeptide; Plant Extracts; Plant Leaves; Plant Proteins; Plant Roots; Plaque, Atherosclerotic; Pneumonia; Pneumonia, Viral; Point-of-Care Testing; Polyethylene Glycols; Polymers; Polysorbates; Pore Forming Cytotoxic Proteins; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Postprandial Period; Poverty; Pre-Exposure Prophylaxis; Prediabetic State; Predictive Value of Tests; Pregnancy; Pregnancy Trimester, First; Pregnancy, High-Risk; Prenatal Exposure Delayed Effects; Pressure; Prevalence; Primary Graft Dysfunction; Primary Health Care; Professional Role; Professionalism; Prognosis; Progression-Free Survival; Prolactin; Promoter Regions, Genetic; Proof of Concept Study; Proportional Hazards Models; Propylene Glycol; Prospective Studies; Prostate; Protein Binding; Protein Biosynthesis; Protein Isoforms; Protein Kinase Inhibitors; Protein Phosphatase 2; Protein Processing, Post-Translational; Protein Serine-Threonine Kinases; Protein Structure, Tertiary; Protein Transport; Proteoglycans; Proteome; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-myc; Proto-Oncogene Proteins c-ret; Proto-Oncogene Proteins p21(ras); Proton Pumps; Protons; Protoporphyrins; Pseudomonas aeruginosa; Pseudomonas fluorescens; Pulmonary Artery; Pulmonary Disease, Chronic Obstructive; Pulmonary Gas Exchange; Pulmonary Veins; Pyrazoles; Pyridines; Pyrimidines; Qualitative Research; Quinoxalines; Rabbits; Random Allocation; Rats; Rats, Sprague-Dawley; Rats, Wistar; Receptors, Histamine H3; Receptors, Immunologic; Receptors, Transferrin; Recombinant Proteins; Recurrence; Reference Values; Referral and Consultation; Regional Blood Flow; Registries; Regulon; Renal Insufficiency, Chronic; Reperfusion Injury; Repressor Proteins; Reproducibility of Results; Republic of Korea; Research Design; Resistance Training; Respiration, Artificial; Respiratory Distress Syndrome; Respiratory Insufficiency; Resuscitation; Retinal Dehydrogenase; Retreatment; Retrospective Studies; Reverse Transcriptase Inhibitors; Rhinitis, Allergic; Ribosomal Proteins; Ribosomes; Risk Assessment; Risk Factors; Ritonavir; Rivers; RNA Interference; RNA-Seq; RNA, Messenger; RNA, Ribosomal, 16S; RNA, Small Interfering; Rosuvastatin Calcium; Rural Population; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salivary Ducts; Salivary Gland Neoplasms; San Francisco; SARS-CoV-2; Satiation; Satiety Response; Schools; Schools, Pharmacy; Seasons; Seawater; Selection, Genetic; Sequence Analysis, DNA; Serine-Threonine Kinase 3; Sewage; Sheep; Sheep, Domestic; Shock, Hemorrhagic; Signal Transduction; Silver; Silymarin; Single Photon Emission Computed Tomography Computed Tomography; Sirolimus; Sirtuin 1; Skin; Skin Neoplasms; Skin Physiological Phenomena; Sleep Initiation and Maintenance Disorders; Social Class; Social Participation; Social Support; Soil; Soil Microbiology; Solutions; Somatomedins; Soot; Specimen Handling; Spectrophotometry, Ultraviolet; Spectroscopy, Fourier Transform Infrared; Spectrum Analysis; Spinal Fractures; Spirometry; Staphylococcus aureus; STAT1 Transcription Factor; STAT3 Transcription Factor; Streptomyces coelicolor; Stress, Psychological; Stroke; Stroke Volume; Structure-Activity Relationship; Students, Medical; Students, Pharmacy; Substance Abuse Treatment Centers; Sulfur Dioxide; Surface Properties; Surface-Active Agents; Surveys and Questionnaires; Survival Analysis; Survival Rate; Survivin; Sweden; Swine; Swine, Miniature; Sympathetic Nervous System; T-Lymphocytes, Regulatory; Talaromyces; Tandem Mass Spectrometry; tau Proteins; Telemedicine; Telomerase; Telomere; Telomere Homeostasis; Temperature; Terminally Ill; Th1 Cells; Thiamethoxam; Thiazoles; Thiophenes; Thioredoxin Reductase 1; Thrombosis; Thulium; Thyroid Cancer, Papillary; Thyroid Carcinoma, Anaplastic; Thyroid Neoplasms; Time Factors; Titanium; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Transcription Factor AP-1; Transcription Factors; Transcription, Genetic; Transcriptional Activation; Transcriptome; Transforming Growth Factor beta1; Transistors, Electronic; Translational Research, Biomedical; Transplantation Tolerance; Transplantation, Homologous; Transportation; Treatment Outcome; Tretinoin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Tubulin Modulators; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Twins; Ultrasonic Therapy; Ultrasonography; Ultraviolet Rays; United States; Up-Regulation; Uranium; Urethra; Urinary Bladder; Urodynamics; Uromodulin; Uveitis; Vasoconstrictor Agents; Ventricular Function, Left; Vero Cells; Vesicular Transport Proteins; Viral Nonstructural Proteins; Visual Acuity; Vital Capacity; Vitamin D; Vitamin D Deficiency; Vitamin K 2; Vitamins; Volatilization; Voriconazole; Waiting Lists; Waste Disposal, Fluid; Wastewater; Water Pollutants, Chemical; Whole Genome Sequencing; Wine; Wnt Signaling Pathway; Wound Healing; Wounds and Injuries; WW Domains; X-linked Nuclear Protein; X-Ray Diffraction; Xanthines; Xenograft Model Antitumor Assays; YAP-Signaling Proteins; Yogurt; Young Adult; Zebrafish; Zebrafish Proteins; Ziziphus

2016
Increase in incidence of hepatic tumors caused by oncogenic somatic mutation in mice maternally exposed to inorganic arsenic and the multigenerational and transgenerational effects of inorganic arsenic.
    Nihon eiseigaku zasshi. Japanese journal of hygiene, 2014, Volume: 69, Issue:2

    Topics: Animals; Arsenic; DNA Methylation; Epigenesis, Genetic; Female; Humans; Liver Neoplasms; Maternal Exposure; Mice; Mutation

2014
Association of inorganic arsenic exposure with liver cancer mortality: A meta-analysis.
    Environmental research, 2014, Volume: 135

    Topics: Arsenic; China; Drinking Water; Environmental Exposure; Female; Humans; Liver Neoplasms; Male; Risk Factors; Water Pollutants, Chemical

2014
Non‑infective occupational risk factors for hepatocellular carcinoma: A review (Review).
    Molecular medicine reports, 2017, Volume: 15, Issue:2

    Topics: Arsenic; Cadmium; Carcinoma, Hepatocellular; Dioxins; Humans; Liver Neoplasms; Nitrosamines; Occupational Exposure; Pesticides; Polychlorinated Biphenyls; Risk Factors

2017
Liver is a target of arsenic carcinogenesis.
    Toxicological sciences : an official journal of the Society of Toxicology, 2008, Volume: 105, Issue:1

    Topics: Animals; Apoptosis; Arsenic; Carcinoma, Hepatocellular; DNA Damage; DNA Methylation; DNA Repair; Estrogens; Humans; Liver; Liver Neoplasms; Mice

2008
MicroRNA response to environmental mutagens in liver.
    Mutation research, 2011, Dec-01, Volume: 717, Issue:1-2

    Topics: Aflatoxin B1; Animals; Arsenic; Benzo(a)pyrene; Carcinoma, Hepatocellular; Environmental Pollutants; Ethanol; Gene Expression Regulation; Hepacivirus; Hepatitis B virus; Humans; Liver; Liver Neoplasms; MicroRNAs; Mutagens; Nicotiana; Poisons; Risk Factors; Rodenticides; Triazines

2011
Arsenic, vinyl chloride, viral hepatitis, and hepatic angiosarcoma: a hospital-based study and review of literature in Taiwan.
    BMC gastroenterology, 2011, Dec-26, Volume: 11

    Topics: Aged; Aged, 80 and over; Arsenic; Female; Hemangiosarcoma; Hepatitis C; Hospitals, Teaching; Humans; Liver Neoplasms; Male; Middle Aged; Retrospective Studies; Taiwan; Tomography, X-Ray Computed; Vinyl Chloride

2011
Does arsenic exposure increase the risk for liver cancer?
    Journal of toxicology and environmental health. Part A, 2004, Oct-08, Volume: 67, Issue:19

    Topics: Arsenic; Arsenic Poisoning; Carcinoma, Hepatocellular; Environmental Exposure; Female; Humans; Liver Neoplasms; Male; Risk; Sex Factors; Taiwan; Water Pollution, Chemical; Water Supply

2004
Environmental factors and risk for hepatocellular carcinoma.
    Gastroenterology, 2004, Volume: 127, Issue:5 Suppl 1

    Topics: Aflatoxins; Alcohol Drinking; Antioxidants; Arsenic; Carcinoma, Hepatocellular; Contraceptives, Oral; Diabetes Complications; Hepacivirus; Hepatitis B virus; Hepatitis B, Chronic; Hepatitis C, Chronic; Humans; Liver Cirrhosis; Liver Neoplasms; Obesity; Risk Factors; Smoking

2004
Chronic arsenic poisoning from burning high-arsenic-containing coal in Guizhou, China.
    Environmental health perspectives, 2002, Volume: 110, Issue:2

    Topics: Adult; Aged; Arsenic; China; Coal; Environmental Exposure; Epidemiologic Studies; Female; Food Contamination; Humans; Incineration; Liver Diseases; Liver Neoplasms; Male; Middle Aged; Mining; Prevalence; Risk Assessment; Skin Diseases; Skin Neoplasms; Water Supply

2002
[Occupational liver lesions].
    Medizinische Klinik, 1977, Nov-11, Volume: 72, Issue:45

    Topics: Arsenic; Cadmium; Chemical and Drug Induced Liver Injury; Chromium; Fatty Liver; Humans; Liver Cirrhosis; Liver Neoplasms; Occupational Diseases; Paraquat; Time Factors; Vinyl Chloride

1977
Environmental hepatic injury in man.
    Progress in liver diseases, 1979, Volume: 6

    Topics: Adolescent; Adult; Aged; Animals; Arsenic; Carcinogens; Chemical and Drug Induced Liver Injury; Child; Child, Preschool; Drug-Related Side Effects and Adverse Reactions; Environmental Pollutants; Female; Hemangiosarcoma; Humans; Infant; Infant, Newborn; Liver Neoplasms; Male; Middle Aged; Necrosis; Pharmacology; Thorium Dioxide; Vinyl Chloride

1979
Primary angiosarcoma of the liver. Review article.
    International surgery, 1975, Volume: 60, Issue:4

    Topics: Adolescent; Adult; Arsenic; Child; Child, Preschool; Chlorides; Female; Hemangiosarcoma; Humans; Infant; Liver Neoplasms; Male; Neoplasm Metastasis; Neoplasms, Radiation-Induced; Occupational Diseases; Prognosis; Thorium Dioxide; Vinyl Compounds

1975
Cancer risks from arsenic in drinking water.
    Environmental health perspectives, 1992, Volume: 97

    Topics: Animals; Arsenic; Case-Control Studies; Dose-Response Relationship, Drug; Female; Humans; Kidney Neoplasms; Liver Neoplasms; Lung Neoplasms; Male; Maximum Allowable Concentration; Mice; Neoplasms; Rats; Rats, Wistar; Taiwan; United States; United States Environmental Protection Agency; Urinary Bladder Neoplasms; Water Pollutants; Water Supply

1992
Arsenic exposure: health effects and the risk of cancer.
    Reviews on environmental health, 1985, Volume: 5, Issue:1

    Topics: Absorption; Arsenic; Arsenic Poisoning; Diet; Gastrointestinal Neoplasms; Humans; Kidney Neoplasms; Leukemia; Liver Neoplasms; Mutagens; Neoplasms; Occupational Diseases; Respiratory Tract Neoplasms; Risk; Skin Neoplasms; Teratogens

1985

Trials

11 trial(s) available for arsenic and Cancer of Liver

ArticleYear
Effects of arsenic trioxide on the expression of ezrin in hepatocellular carcinoma.
    Medicine, 2017, Volume: 96, Issue:35

    Topics: Adult; Aged; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Carcinoma, Hepatocellular; Cytoskeletal Proteins; Female; Humans; Immunohistochemistry; Infusions, Intravenous; Liver Neoplasms; Male; Middle Aged; Oxides

2017
Arsenic trioxide transarterial chemoembolization with and without additional intravenous administration of arsenic trioxide in unresectable hepatocellular carcinoma with lung metastasis: a single-blind, randomized trial.
    Journal of cancer research and clinical oncology, 2015, Volume: 141, Issue:6

    Topics: Adult; Aged; Analysis of Variance; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Biomarkers, Tumor; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; China; Combined Modality Therapy; Drug Administration Schedule; Female; Hepatic Artery; Humans; Infusions, Intravenous; Kaplan-Meier Estimate; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Oxides; Single-Blind Method; Treatment Outcome; Tumor Burden

2015
Randomized clinical control study of locoregional therapy combined with arsenic trioxide for the treatment of hepatocellular carcinoma.
    Cancer, 2015, Sep-01, Volume: 121, Issue:17

    Topics: Adult; Aged; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Combined Modality Therapy; Female; Humans; Kaplan-Meier Estimate; Liver Neoplasms; Male; Middle Aged; Oxides; Proportional Hazards Models; Treatment Outcome

2015
Arsenic trioxide in patients with adenocarcinoma of the pancreas refractory to gemcitabine: a phase II trial of the University of Chicago Phase II Consortium.
    American journal of clinical oncology, 2008, Volume: 31, Issue:6

    Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Deoxycytidine; Disease-Free Survival; Drug Resistance, Neoplasm; Gemcitabine; Humans; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Oxides; Pancreatic Neoplasms; Salvage Therapy; Survival Rate; Treatment Outcome

2008
Phase II study of darinaparsin in patients with advanced hepatocellular carcinoma.
    Investigational new drugs, 2010, Volume: 28, Issue:5

    Topics: Adult; Aged; Antineoplastic Agents; Arsenicals; Carcinoma, Hepatocellular; Disease-Free Survival; Female; Glutathione; Humans; Liver Neoplasms; Male; Middle Aged; Neoplasm Staging; Treatment Outcome

2010
[Multicenter phase II clinical trial of arsenic trioxide injection in the treatment of primary hepatocarcinoma].
    Zhonghua zhong liu za zhi [Chinese journal of oncology], 2011, Volume: 33, Issue:9

    Topics: Adult; Aged; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Carcinoma, Hepatocellular; Disease Progression; Female; Follow-Up Studies; Half-Life; Humans; Injections; Leukopenia; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Nausea; Neoplasm Staging; Oxides; Quality of Life; Remission Induction; Survival Rate; Vomiting

2011
[The clinical therapeutic effects of arsenic trioxide combined with transcatheter arterial chemoembolization in treating primary liver cancer with pulmonary metastases].
    Zhonghua nei ke za zhi, 2012, Volume: 51, Issue:12

    Topics: Adult; Aged; Arsenic Trioxide; Arsenicals; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Combined Modality Therapy; Female; Humans; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Oxides; Treatment Outcome

2012
Arsenic trioxide in patients with hepatocellular carcinoma: a phase II trial.
    Investigational new drugs, 2007, Volume: 25, Issue:1

    Topics: Adult; Aged; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Carcinoma, Hepatocellular; Drug Administration Schedule; Fatigue; Female; Humans; Injections, Intravenous; Leukopenia; Liver Neoplasms; Male; Middle Aged; Neoplasm Staging; Neutropenia; Oxides; Survival Analysis; Treatment Outcome

2007
[Arsenic trioxide for the treatment of medium and advanced primary liver cancer].
    Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology, 2002, Volume: 10, Issue:1

    Topics: Adult; Aged; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Chemical and Drug Induced Liver Injury; Female; Humans; Liver Neoplasms; Male; Middle Aged; Oxides; Remission Induction; Treatment Outcome; Vomiting

2002
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor Proteins, Signal Transducing; Adenine; Adenocarcinoma; Adipogenesis; Administration, Cutaneous; Administration, Ophthalmic; Adolescent; Adsorption; Adult; Aeromonas hydrophila; Aerosols; Aged; Aged, 80 and over; Aging; Agriculture; Air Pollutants; Air Pollution; Airway Remodeling; Alanine Transaminase; Albuminuria; Aldehyde Dehydrogenase 1 Family; Algorithms; AlkB Homolog 2, Alpha-Ketoglutarate-Dependent Dioxygenase; Alzheimer Disease; Amino Acid Sequence; Ammonia; Ammonium Compounds; Anaerobiosis; Anesthetics, Dissociative; Anesthetics, Inhalation; Animals; Anti-Bacterial Agents; Anti-HIV Agents; Anti-Infective Agents; Anti-Inflammatory Agents; Antibiotics, Antineoplastic; Antibodies, Antineutrophil Cytoplasmic; Antibodies, Monoclonal, Humanized; Antifungal Agents; Antigens, Bacterial; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antitubercular Agents; Antiviral Agents; Apolipoproteins E; Apoptosis; Arabidopsis; Arabidopsis Proteins; Arsenic; Arthritis, Rheumatoid; Asthma; Atherosclerosis; ATP-Dependent Proteases; Attitude of Health Personnel; Australia; Austria; Autophagy; Axitinib; Bacteria; Bacterial Outer Membrane Proteins; Bacterial Proteins; Bacterial Toxins; Bacterial Typing Techniques; Bariatric Surgery; Base Composition; Bayes Theorem; Benzoxazoles; Benzylamines; beta Catenin; Betacoronavirus; Betula; Binding Sites; Biological Availability; Biological Oxygen Demand Analysis; Biomarkers; Biomarkers, Tumor; Biopsy; Bioreactors; Biosensing Techniques; Birth Weight; Blindness; Blood Chemical Analysis; Blood Gas Analysis; Blood Glucose; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Blood-Brain Barrier; Blotting, Western; Body Mass Index; Body Weight; Bone and Bones; Bone Density; Bone Resorption; Borates; Brain; Brain Infarction; Brain Injuries, Traumatic; Brain Neoplasms; Breakfast; Breast Milk Expression; Breast Neoplasms; Bronchi; Bronchoalveolar Lavage Fluid; Buffaloes; Cadherins; Calcification, Physiologic; Calcium Compounds; Calcium, Dietary; Cannula; Caprolactam; Carbon; Carbon Dioxide; Carboplatin; Carcinogenesis; Carcinoma, Ductal; Carcinoma, Ehrlich Tumor; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Pancreatic Ductal; Carcinoma, Renal Cell; Cardiovascular Diseases; Carps; Carrageenan; Case-Control Studies; Catalysis; Catalytic Domain; Cattle; CD8-Positive T-Lymphocytes; Cell Adhesion; Cell Cycle Proteins; Cell Death; Cell Differentiation; Cell Line; Cell Line, Tumor; Cell Movement; Cell Nucleus; Cell Phone Use; Cell Proliferation; Cell Survival; Cell Transformation, Neoplastic; Cell Transformation, Viral; Cells, Cultured; Cellulose; Chemical Phenomena; Chemoradiotherapy; Child; Child Development; Child, Preschool; China; Chitosan; Chlorocebus aethiops; Cholecalciferol; Chromatography, Liquid; Circadian Clocks; Circadian Rhythm; Circular Dichroism; Cisplatin; Citric Acid; Clinical Competence; Clinical Laboratory Techniques; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Clostridioides difficile; Clostridium Infections; Coculture Techniques; Cohort Studies; Cold Temperature; Colitis; Collagen Type I; Collagen Type I, alpha 1 Chain; Collagen Type XI; Color; Connective Tissue Diseases; Copper; Coronary Angiography; Coronavirus 3C Proteases; Coronavirus Infections; Cost of Illness; Counselors; COVID-19; COVID-19 Testing; Creatine Kinase; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Cryoelectron Microscopy; Cryosurgery; Crystallography, X-Ray; Cues; Cultural Competency; Cultural Diversity; Curriculum; Cyclic AMP Response Element-Binding Protein; Cyclin-Dependent Kinase Inhibitor p21; Cycloparaffins; Cysteine Endopeptidases; Cytokines; Cytoplasm; Cytoprotection; Databases, Factual; Denitrification; Deoxycytidine; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diagnosis, Differential; Diatoms; Diet; Diet, High-Fat; Dietary Exposure; Diffusion Magnetic Resonance Imaging; Diketopiperazines; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Disease Models, Animal; Disease Progression; Disease-Free Survival; DNA; DNA Damage; DNA Glycosylases; DNA Repair; DNA-Binding Proteins; DNA, Bacterial; DNA, Viral; Docetaxel; Dose Fractionation, Radiation; Dose-Response Relationship, Drug; Down-Regulation; Doxorubicin; Drosophila; Drosophila melanogaster; Drug Carriers; Drug Delivery Systems; Drug Liberation; Drug Repositioning; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Drug Synergism; Drug Therapy, Combination; Edema; Edible Grain; Education, Graduate; Education, Medical, Graduate; Education, Pharmacy; Ehlers-Danlos Syndrome; Electron Transport Complex III; Electron Transport Complex IV; Electronic Nicotine Delivery Systems; Emergency Service, Hospital; Empathy; Emulsions; Endothelial Cells; Endurance Training; Energy Intake; Enterovirus A, Human; Environment; Environmental Monitoring; Enzyme Assays; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Epoxide Hydrolases; Epoxy Compounds; Erythrocyte Count; Erythrocytes; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Esophagectomy; Estrogens; Etanercept; Ethiopia; Ethnicity; Ethylenes; Exanthema; Exercise; Exercise Test; Exercise Tolerance; Extracellular Matrix; Extracorporeal Membrane Oxygenation; Eye Infections, Fungal; False Negative Reactions; Fatty Acids; Fecal Microbiota Transplantation; Feces; Female; Femur Neck; Fermentation; Ferritins; Fetal Development; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Fibroblasts; Fibroins; Fish Proteins; Flavanones; Flavonoids; Focus Groups; Follow-Up Studies; Food Handling; Food Supply; Food, Formulated; Forced Expiratory Volume; Forests; Fractures, Bone; Fruit and Vegetable Juices; Fusobacteria; G1 Phase Cell Cycle Checkpoints; G2 Phase Cell Cycle Checkpoints; Gamma Rays; Gastrectomy; Gastrointestinal Microbiome; Gastrointestinal Stromal Tumors; Gefitinib; Gels; Gemcitabine; Gene Amplification; Gene Expression; Gene Expression Regulation; Gene Expression Regulation, Bacterial; Gene Expression Regulation, Neoplastic; Gene Expression Regulation, Plant; Gene Knockdown Techniques; Gene-Environment Interaction; Genotype; Germany; Glioma; Glomerular Filtration Rate; Glucagon; Glucocorticoids; Glycemic Control; Glycerol; Glycogen Synthase Kinase 3 beta; Glycolipids; Glycolysis; Goblet Cells; Gram-Negative Bacterial Infections; Granulocyte Colony-Stimulating Factor; Graphite; Greenhouse Effect; Guanidines; Haemophilus influenzae; HCT116 Cells; Health Knowledge, Attitudes, Practice; Health Personnel; Health Services Accessibility; Health Services Needs and Demand; Health Status Disparities; Healthy Volunteers; Heart Failure; Heart Rate; Heart Transplantation; Heart-Assist Devices; HEK293 Cells; Heme; Heme Oxygenase-1; Hemolysis; Hemorrhage; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Hepatocytes; Hexoses; High-Throughput Nucleotide Sequencing; Hippo Signaling Pathway; Histamine; Histamine Agonists; Histidine; Histone Deacetylase 2; HIV Infections; HIV Reverse Transcriptase; HIV-1; Homebound Persons; Homeodomain Proteins; Homosexuality, Male; Hospice and Palliative Care Nursing; HSP70 Heat-Shock Proteins; Humans; Hyaluronan Receptors; Hydrogen; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrolysis; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypoglycemia; Hypoglycemic Agents; Hypoxia; Idiopathic Interstitial Pneumonias; Imaging, Three-Dimensional; Imatinib Mesylate; Immunotherapy; Implementation Science; Incidence; INDEL Mutation; Induced Pluripotent Stem Cells; Industrial Waste; Infant; Infant, Newborn; Inflammation; Inflammation Mediators; Infliximab; Infusions, Intravenous; Inhibitory Concentration 50; Injections; Insecticides; Insulin-Like Growth Factor Binding Protein 5; Insulin-Secreting Cells; Interleukin-1; Interleukin-17; Interleukin-8; Internship and Residency; Intestines; Intracellular Signaling Peptides and Proteins; Ion Transport; Iridaceae; Iridoid Glucosides; Islets of Langerhans Transplantation; Isodon; Isoflurane; Isotopes; Italy; Joint Instability; Ketamine; Kidney; Kidney Failure, Chronic; Kidney Function Tests; Kidney Neoplasms; Kinetics; Klebsiella pneumoniae; Knee Joint; Kruppel-Like Factor 4; Kruppel-Like Transcription Factors; Lactate Dehydrogenase 5; Laparoscopy; Laser Therapy; Lasers, Semiconductor; Lasers, Solid-State; Laurates; Lead; Leukocyte L1 Antigen Complex; Leukocytes, Mononuclear; Light; Lipid Peroxidation; Lipopolysaccharides; Liposomes; Liver; Liver Cirrhosis; Liver Neoplasms; Liver Transplantation; Locomotion; Longitudinal Studies; Lopinavir; Lower Urinary Tract Symptoms; Lubricants; Lung; Lung Diseases, Interstitial; Lung Neoplasms; Lymphocyte Activation; Lymphocytes, Tumor-Infiltrating; Lymphoma, Mantle-Cell; Lysosomes; Macrophages; Male; Manganese Compounds; MAP Kinase Kinase 4; Mass Screening; Maternal Health; Medicine, Chinese Traditional; Melanoma, Experimental; Memantine; Membrane Glycoproteins; Membrane Proteins; Mesenchymal Stem Cell Transplantation; Metal Nanoparticles; Metalloendopeptidases; Metalloporphyrins; Methadone; Methane; Methicillin-Resistant Staphylococcus aureus; Mexico; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Inbred ICR; Mice, Knockout; Mice, Nude; Mice, SCID; Mice, Transgenic; Microarray Analysis; Microbial Sensitivity Tests; Microbiota; Micronutrients; MicroRNAs; Microscopy, Confocal; Microsomes, Liver; Middle Aged; Milk; Milk, Human; Minority Groups; Mitochondria; Mitochondrial Membranes; Mitochondrial Proteins; Models, Animal; Models, Molecular; Molecular Conformation; Molecular Docking Simulation; Molecular Dynamics Simulation; Molecular Epidemiology; Molecular Structure; Molecular Weight; Multilocus Sequence Typing; Multimodal Imaging; Muscle Strength; Muscle, Skeletal; Muscular Diseases; Mutation; Mycobacterium tuberculosis; Myocardial Stunning; Myristates; NAD(P)H Dehydrogenase (Quinone); Nanocomposites; Nanogels; Nanoparticles; Nanotechnology; Naphthalenes; Nasal Cavity; National Health Programs; Necrosis; Needs Assessment; Neoadjuvant Therapy; Neonicotinoids; Neoplasm Invasiveness; Neoplasm Metastasis; Neoplasm Proteins; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasm Transplantation; Neoplasms; Neoplastic Stem Cells; Netherlands; Neuroblastoma; Neuroprotective Agents; Neutrophils; NF-kappa B; NFATC Transcription Factors; Nicotiana; Nicotine; Nitrates; Nitrification; Nitrites; Nitro Compounds; Nitrogen; Nitrogen Dioxide; North Carolina; Nuclear Magnetic Resonance, Biomolecular; Nuclear Proteins; Nucleic Acid Hybridization; Nucleosomes; Nutrients; Obesity; Obesity, Morbid; Oceans and Seas; Oncogene Protein v-akt; Oncogenes; Oocytes; Open Reading Frames; Osteoclasts; Osteogenesis; Osteoporosis; Osteoporosis, Postmenopausal; Outpatients; Ovarian Neoplasms; Ovariectomy; Overweight; Oxazines; Oxidants; Oxidation-Reduction; Oxidative Stress; Oxides; Oxidoreductases; Oxygen; Oxygen Inhalation Therapy; Oxygenators, Membrane; Ozone; Paclitaxel; Paenibacillus; Pain Measurement; Palliative Care; Pancreatic Neoplasms; Pandemics; Parasympathetic Nervous System; Particulate Matter; Pasteurization; Patient Preference; Patient Satisfaction; Pediatric Obesity; Permeability; Peroxiredoxins; Peroxynitrous Acid; Pharmaceutical Services; Pharmacists; Pharmacy; Phaseolus; Phenotype; Phoeniceae; Phosphates; Phosphatidylinositol 3-Kinases; Phospholipid Transfer Proteins; Phospholipids; Phosphorus; Phosphorylation; Photoperiod; Photosynthesis; Phylogeny; Physical Endurance; Physicians; Pilot Projects; Piperidines; Pituitary Adenylate Cyclase-Activating Polypeptide; Plant Extracts; Plant Leaves; Plant Proteins; Plant Roots; Plaque, Atherosclerotic; Pneumonia; Pneumonia, Viral; Point-of-Care Testing; Polyethylene Glycols; Polymers; Polysorbates; Pore Forming Cytotoxic Proteins; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Postprandial Period; Poverty; Pre-Exposure Prophylaxis; Prediabetic State; Predictive Value of Tests; Pregnancy; Pregnancy Trimester, First; Pregnancy, High-Risk; Prenatal Exposure Delayed Effects; Pressure; Prevalence; Primary Graft Dysfunction; Primary Health Care; Professional Role; Professionalism; Prognosis; Progression-Free Survival; Prolactin; Promoter Regions, Genetic; Proof of Concept Study; Proportional Hazards Models; Propylene Glycol; Prospective Studies; Prostate; Protein Binding; Protein Biosynthesis; Protein Isoforms; Protein Kinase Inhibitors; Protein Phosphatase 2; Protein Processing, Post-Translational; Protein Serine-Threonine Kinases; Protein Structure, Tertiary; Protein Transport; Proteoglycans; Proteome; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-myc; Proto-Oncogene Proteins c-ret; Proto-Oncogene Proteins p21(ras); Proton Pumps; Protons; Protoporphyrins; Pseudomonas aeruginosa; Pseudomonas fluorescens; Pulmonary Artery; Pulmonary Disease, Chronic Obstructive; Pulmonary Gas Exchange; Pulmonary Veins; Pyrazoles; Pyridines; Pyrimidines; Qualitative Research; Quinoxalines; Rabbits; Random Allocation; Rats; Rats, Sprague-Dawley; Rats, Wistar; Receptors, Histamine H3; Receptors, Immunologic; Receptors, Transferrin; Recombinant Proteins; Recurrence; Reference Values; Referral and Consultation; Regional Blood Flow; Registries; Regulon; Renal Insufficiency, Chronic; Reperfusion Injury; Repressor Proteins; Reproducibility of Results; Republic of Korea; Research Design; Resistance Training; Respiration, Artificial; Respiratory Distress Syndrome; Respiratory Insufficiency; Resuscitation; Retinal Dehydrogenase; Retreatment; Retrospective Studies; Reverse Transcriptase Inhibitors; Rhinitis, Allergic; Ribosomal Proteins; Ribosomes; Risk Assessment; Risk Factors; Ritonavir; Rivers; RNA Interference; RNA-Seq; RNA, Messenger; RNA, Ribosomal, 16S; RNA, Small Interfering; Rosuvastatin Calcium; Rural Population; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salivary Ducts; Salivary Gland Neoplasms; San Francisco; SARS-CoV-2; Satiation; Satiety Response; Schools; Schools, Pharmacy; Seasons; Seawater; Selection, Genetic; Sequence Analysis, DNA; Serine-Threonine Kinase 3; Sewage; Sheep; Sheep, Domestic; Shock, Hemorrhagic; Signal Transduction; Silver; Silymarin; Single Photon Emission Computed Tomography Computed Tomography; Sirolimus; Sirtuin 1; Skin; Skin Neoplasms; Skin Physiological Phenomena; Sleep Initiation and Maintenance Disorders; Social Class; Social Participation; Social Support; Soil; Soil Microbiology; Solutions; Somatomedins; Soot; Specimen Handling; Spectrophotometry, Ultraviolet; Spectroscopy, Fourier Transform Infrared; Spectrum Analysis; Spinal Fractures; Spirometry; Staphylococcus aureus; STAT1 Transcription Factor; STAT3 Transcription Factor; Streptomyces coelicolor; Stress, Psychological; Stroke; Stroke Volume; Structure-Activity Relationship; Students, Medical; Students, Pharmacy; Substance Abuse Treatment Centers; Sulfur Dioxide; Surface Properties; Surface-Active Agents; Surveys and Questionnaires; Survival Analysis; Survival Rate; Survivin; Sweden; Swine; Swine, Miniature; Sympathetic Nervous System; T-Lymphocytes, Regulatory; Talaromyces; Tandem Mass Spectrometry; tau Proteins; Telemedicine; Telomerase; Telomere; Telomere Homeostasis; Temperature; Terminally Ill; Th1 Cells; Thiamethoxam; Thiazoles; Thiophenes; Thioredoxin Reductase 1; Thrombosis; Thulium; Thyroid Cancer, Papillary; Thyroid Carcinoma, Anaplastic; Thyroid Neoplasms; Time Factors; Titanium; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Transcription Factor AP-1; Transcription Factors; Transcription, Genetic; Transcriptional Activation; Transcriptome; Transforming Growth Factor beta1; Transistors, Electronic; Translational Research, Biomedical; Transplantation Tolerance; Transplantation, Homologous; Transportation; Treatment Outcome; Tretinoin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Tubulin Modulators; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Twins; Ultrasonic Therapy; Ultrasonography; Ultraviolet Rays; United States; Up-Regulation; Uranium; Urethra; Urinary Bladder; Urodynamics; Uromodulin; Uveitis; Vasoconstrictor Agents; Ventricular Function, Left; Vero Cells; Vesicular Transport Proteins; Viral Nonstructural Proteins; Visual Acuity; Vital Capacity; Vitamin D; Vitamin D Deficiency; Vitamin K 2; Vitamins; Volatilization; Voriconazole; Waiting Lists; Waste Disposal, Fluid; Wastewater; Water Pollutants, Chemical; Whole Genome Sequencing; Wine; Wnt Signaling Pathway; Wound Healing; Wounds and Injuries; WW Domains; X-linked Nuclear Protein; X-Ray Diffraction; Xanthines; Xenograft Model Antitumor Assays; YAP-Signaling Proteins; Yogurt; Young Adult; Zebrafish; Zebrafish Proteins; Ziziphus

2016
Effects of mineral supplementation on liver cirrhotic/cancer male patients.
    Biological trace element research, 2012, Volume: 150, Issue:1-3

    Topics: Adult; Arsenic; Cadmium; Dietary Supplements; Drinking Water; Humans; Liver Cirrhosis; Liver Neoplasms; Male; Microwaves; Middle Aged; Minerals; Pakistan; Selenium; Spectrophotometry, Atomic; Zinc

2012

Other Studies

163 other study(ies) available for arsenic and Cancer of Liver

ArticleYear
Combinatorial Effect of Arsenic and Herbal Compounds in Telomerase-Mediated Apoptosis Induction in Liver Cancer.
    Biological trace element research, 2023, Volume: 201, Issue:7

    Topics: Antineoplastic Agents; Apoptosis; Arsenic; Arsenic Trioxide; Arsenicals; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Emodin; Humans; Liver Neoplasms; Oxides; Quercetin; Telomerase

2023
Induction of filamin-C and its involvement in the regulation of cellular senescence and apoptosis in Huh-7 hepatoma cells during arsenic trioxide exposure.
    Biochemical and biophysical research communications, 2023, 04-09, Volume: 651

    Topics: Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Carcinoma, Hepatocellular; Cell Line, Tumor; Cellular Senescence; Filamins; Humans; Liver Neoplasms; Oxides

2023
Realgar Nanoparticles Inhibit Migration, Invasion and Metastasis in a Mouse Model of Breast Cancer by Suppressing Matrix Metalloproteinases and Angiogenesis.
    Current drug delivery, 2020, Volume: 17, Issue:2

    Topics: Animals; Antineoplastic Agents; Arsenicals; Cell Line, Tumor; Cell Movement; Female; Liver Neoplasms; Lung Neoplasms; Mammary Neoplasms, Experimental; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Matrix Metalloproteinase Inhibitors; Matrix Metalloproteinases; Mice, Inbred BALB C; Nanoparticles; Neovascularization, Pathologic; Sulfides; Wound Healing

2020
[Effect of Cell Autophagy on the Apoptosis of Hepatocellular Carcinoma Cells Induced by Arsenic Trioxide].
    Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition, 2017, Volume: 48, Issue:2

    Topics: Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Autophagy; Beclin-1; Carcinoma, Hepatocellular; Hep G2 Cells; Humans; Liver Neoplasms; Microtubule-Associated Proteins

2017
A carcinogenicity study of diphenylarsinic acid in F344 rats in drinking water for 104 weeks.
    The Journal of toxicological sciences, 2017, Volume: 42, Issue:4

    Topics: Administration, Oral; Animals; Arsenicals; Body Weight; Chemical Warfare Agents; Dose-Response Relationship, Drug; Female; Liver Neoplasms; Male; Rats, Inbred F344; Survival Rate; Time Factors; Water; Water Pollutants, Chemical

2017
Phenylarsine oxide (PAO) induces apoptosis in HepG2 cells via ROS-mediated mitochondria and ER-stress dependent signaling pathways.
    Metallomics : integrated biometal science, 2017, 12-01, Volume: 9, Issue:12

    Topics: Apoptosis; Arsenicals; Carcinoma, Hepatocellular; Endoplasmic Reticulum Stress; Humans; Liver Neoplasms; Mitochondria; Platelet Aggregation Inhibitors; Reactive Oxygen Species; Signal Transduction; Tumor Cells, Cultured

2017
Low dosage of arsenic trioxide inhibits vasculogenic mimicry in hepatoblastoma without cell apoptosis.
    Molecular medicine reports, 2018, Volume: 17, Issue:1

    Topics: Angiogenesis Inhibitors; Animals; Apoptosis; Arsenic Trioxide; Arsenicals; Cell Survival; Dose-Response Relationship, Drug; Hep G2 Cells; Hepatoblastoma; Humans; Liver Neoplasms; Male; Mice, Nude; Neovascularization, Pathologic; Oxides; Xenograft Model Antitumor Assays

2018
γ-Glutamylcysteine synthetase (γ-GCS) as a target for overcoming chemo- and radio-resistance of human hepatocellular carcinoma cells.
    Life sciences, 2018, Apr-01, Volume: 198

    Topics: Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Carcinoma, Hepatocellular; Catalysis; Chromatography, High Pressure Liquid; Drug Resistance, Neoplasm; Glutamate-Cysteine Ligase; Hep G2 Cells; Humans; Liver Neoplasms; Membrane Potential, Mitochondrial; Oxides; Radiation Tolerance; Reactive Oxygen Species

2018
Arsenic trioxide induces apoptosis and inhibits the growth of human liver cancer cells.
    Life sciences, 2018, Jul-15, Volume: 205

    Topics: Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; bcl-X Protein; Carcinoma, Hepatocellular; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Survival; Down-Regulation; Humans; Liver Neoplasms; Oxides; Receptors, Notch

2018
Icariin synergizes with arsenic trioxide to suppress human hepatocellular carcinoma.
    Cell biochemistry and biophysics, 2014, Volume: 68, Issue:2

    Topics: Animals; Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Drug Synergism; Female; Flavonoids; Humans; Liver Neoplasms; Membrane Potential, Mitochondrial; Mice; Mice, Inbred BALB C; Mice, Nude; NF-kappa B; Oxides; Reactive Oxygen Species; Transplantation, Heterologous

2014
Diphenylarsinic acid, a chemical warfare-related neurotoxicant, promotes liver carcinogenesis via activation of aryl hydrocarbon receptor signaling and consequent induction of oxidative DNA damage in rats.
    Toxicology and applied pharmacology, 2013, Nov-15, Volume: 273, Issue:1

    Topics: Animals; Apoptosis; Arsenicals; Aryl Hydrocarbon Hydroxylases; bcl-2-Associated X Protein; Body Weight; Carcinogenesis; Carcinogens; Chemical Warfare Agents; Cytochrome P-450 CYP1B1; Diethylnitrosamine; DNA Damage; Japan; Liver; Liver Neoplasms; Male; Neurotoxins; Organ Size; Oxidative Stress; Rats; Rats, Inbred F344; Receptors, Aryl Hydrocarbon; Signal Transduction; Transcriptional Activation

2013
Arsenic trioxide induces differentiation of CD133+ hepatocellular carcinoma cells and prolongs posthepatectomy survival by targeting GLI1 expression in a mouse model.
    Journal of hematology & oncology, 2014, Mar-30, Volume: 7

    Topics: AC133 Antigen; Animals; Antigens, CD; Arsenic Trioxide; Arsenicals; Carcinoma, Hepatocellular; Cell Differentiation; Cell Line, Tumor; Disease Models, Animal; Down-Regulation; Glycoproteins; Humans; Liver Neoplasms; Male; Mice; Mice, Inbred NOD; Mice, SCID; Neoplasm Recurrence, Local; Neoplastic Stem Cells; Oxides; Peptides; Random Allocation; Signal Transduction; Survival Analysis; Transcription Factors; Xenograft Model Antitumor Assays; Zinc Finger Protein GLI1

2014
Arsenic trioxide attenuates the invasion potential of human liver cancer cells through the demethylation-activated microRNA-491.
    Toxicology letters, 2014, Jun-05, Volume: 227, Issue:2

    Topics: Arsenic Trioxide; Arsenicals; Biomarkers; Carcinoma, Hepatocellular; Cell Line, Tumor; Gene Expression Regulation, Neoplastic; Humans; Liver Neoplasms; MicroRNAs; Neoplasm Invasiveness; NF-kappa B; Oxides; Signal Transduction

2014
Arsenic trioxide: marked suppression of tumor metastasis potential by inhibiting the transcription factor Twist in vivo and in vitro.
    Journal of cancer research and clinical oncology, 2014, Volume: 140, Issue:7

    Topics: Animals; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Carcinoma, Hepatocellular; Cell Line, Tumor; Down-Regulation; Embolization, Therapeutic; Liver Neoplasms; Lung Neoplasms; Male; Neoplasm Metastasis; Oxides; Rats; Rats, Inbred BUF; Twist-Related Protein 1

2014
Humanized anti-VEGFR-2 ScFv-As2O3-stealth nanoparticles, an antibody conjugate with potent and selective anti-hepatocellular carcinoma activity.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2014, Volume: 68, Issue:5

    Topics: Animals; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Humans; Immunohistochemistry; Leukocyte Count; Liver Neoplasms; Male; Mice, Nude; Microvessels; Nanoparticles; Oxides; Platelet Count; Single-Chain Antibodies; Tissue Distribution; Vascular Endothelial Growth Factor Receptor-2

2014
Nutlin-3 overcomes arsenic trioxide resistance and tumor metastasis mediated by mutant p53 in Hepatocellular Carcinoma.
    Molecular cancer, 2014, May-31, Volume: 13

    Topics: Animals; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Carcinoma, Hepatocellular; Cell Line, Tumor; DNA-Binding Proteins; Drug Resistance, Neoplasm; Drug Synergism; Epithelial-Mesenchymal Transition; Gene Expression Regulation, Neoplastic; Humans; Imidazoles; Liver Neoplasms; Lung Neoplasms; Mice; Mice, Nude; Mutation; Neoplasm Transplantation; Nuclear Proteins; Oxides; Piperazines; Signal Transduction; Tumor Protein p73; Tumor Suppressor Protein p53; Tumor Suppressor Proteins

2014
Exposure of hepatocellular carcinoma cells to low-level As₂O₃‎ causes an extra toxicity pathway via L1 retrotransposition ‎induction.
    Toxicology letters, 2014, Aug-17, Volume: 229, Issue:1

    Topics: Animals; Arsenic Trioxide; Arsenicals; Cell Line, Tumor; Cell Survival; Coloring Agents; Deoxyribonuclease I; DNA; Flow Cytometry; Green Fluorescent Proteins; Humans; Indicators and Reagents; Liver Neoplasms; Liver Neoplasms, Experimental; Microscopy, Fluorescence; Oxides; Plasmids; Real-Time Polymerase Chain Reaction; Retroelements; Tetrazolium Salts; Thiazoles; Transfection

2014
Inhibitory effect of humanized anti-VEGFR-2 ScFv-As2O3-stealth nanoparticles conjugate on growth of human hepatocellular carcinoma: in vitro and in vivo studies.
    Asian Pacific journal of tropical medicine, 2014, Volume: 7, Issue:5

    Topics: Animals; Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Cell Line, Tumor; Cell Movement; Cell Proliferation; Drug Delivery Systems; Humans; Liver Neoplasms; Liver Neoplasms, Experimental; Mice; Microvessels; Nanoparticles; Neovascularization, Pathologic; Oxides; Single-Chain Antibodies; Vascular Endothelial Growth Factor Receptor-2

2014
All-trans retinoic acid and arsenic trioxide induce apoptosis and modulate intracellular concentrations of calcium in hepatocellular carcinoma cells.
    Journal of chemotherapy (Florence, Italy), 2014, Volume: 26, Issue:6

    Topics: Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Calcium; Carcinoma, Hepatocellular; Cell Proliferation; Hep G2 Cells; Humans; Liver Neoplasms; Oxides; Tretinoin

2014
Inhibition of TGF-β/SMAD3/NF-κB signaling by microRNA-491 is involved in arsenic trioxide-induced anti-angiogenesis in hepatocellular carcinoma cells.
    Toxicology letters, 2014, Nov-18, Volume: 231, Issue:1

    Topics: 3' Untranslated Regions; Angiogenesis Inhibitors; Arsenic Trioxide; Arsenicals; Carcinoma, Hepatocellular; Cell Line, Tumor; DNA Methylation; Gene Expression Regulation, Neoplastic; Human Umbilical Vein Endothelial Cells; Humans; Liver Neoplasms; MicroRNAs; Neovascularization, Pathologic; Neovascularization, Physiologic; NF-kappa B; Oxides; RNA Interference; Signal Transduction; Smad3 Protein; Time Factors; Transfection; Transforming Growth Factor beta; Vascular Endothelial Growth Factor A

2014
Inhibition of the cancer stem cells-like properties by arsenic trioxide, involved in the attenuation of endogenous transforming growth factor beta signal.
    Toxicological sciences : an official journal of the Society of Toxicology, 2015, Volume: 143, Issue:1

    Topics: 3' Untranslated Regions; AC133 Antigen; Animals; Antigens, CD; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Carcinoma, Hepatocellular; Cell Line, Tumor; Down-Regulation; Gene Expression Regulation, Neoplastic; Glycoproteins; Humans; Kaplan-Meier Estimate; Liver Neoplasms; Mice, Inbred BALB C; Mice, Nude; MicroRNAs; Neoplastic Stem Cells; Oxides; Peptides; RNA Interference; Signal Transduction; Smad3 Protein; Time Factors; Transfection; Transforming Growth Factor beta; Xenograft Model Antitumor Assays

2015
[The apoptotic mechanism of hepatocellular carcinoma cell line (HepG2) induced by arsenic trioxide].
    Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition, 2014, Volume: 45, Issue:5

    Topics: Apoptosis; Arsenic Trioxide; Arsenicals; Carcinoma, Hepatocellular; Glutamate-Cysteine Ligase; Glutathione; Hep G2 Cells; Humans; Liver Neoplasms; Oxides; Reactive Oxygen Species

2014
Arsenic trioxide potentiates the anti-cancer activities of sorafenib against hepatocellular carcinoma by inhibiting Akt activation.
    Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine, 2015, Volume: 36, Issue:4

    Topics: Animals; Apoptosis; Arsenic Trioxide; Arsenicals; Carcinoma, Hepatocellular; Cell Proliferation; Drug Synergism; Gene Expression Regulation, Neoplastic; Hep G2 Cells; Humans; Liver Neoplasms; Mice; Neoplasm Proteins; Niacinamide; Oxides; Phenylurea Compounds; Proto-Oncogene Proteins c-akt; Signal Transduction; Sorafenib

2015
Metformin sensitizes hepatocellular carcinoma to arsenic trioxide-induced apoptosis by downregulating Bcl2 expression.
    Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine, 2015, Volume: 36, Issue:4

    Topics: Apoptosis; Arsenic Trioxide; Arsenicals; Carcinoma, Hepatocellular; Cell Proliferation; Drug Synergism; Gene Expression Regulation, Neoplastic; Hep G2 Cells; Humans; Liver Neoplasms; Metformin; Oxides; Proto-Oncogene Proteins c-bcl-2

2015
PARP-1 inhibitor sensitizes arsenic trioxide in hepatocellular carcinoma cells via abrogation of G2/M checkpoint and suppression of DNA damage repair.
    Chemico-biological interactions, 2015, Jan-25, Volume: 226

    Topics: 1-Naphthylamine; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Carcinoma, Hepatocellular; Cell Cycle Checkpoints; Cyclin B1; DNA Damage; DNA Repair; Dose-Response Relationship, Drug; Drug Synergism; Enzyme Inhibitors; G2 Phase Cell Cycle Checkpoints; Hep G2 Cells; Humans; Liver Neoplasms; M Phase Cell Cycle Checkpoints; Naphthalimides; Oxides; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Quinolones; Up-Regulation

2015
[4-amino-1,8-naphthalimide on the Sensitive effect of arsenic trioxide in hepatocellular carcinoma cells].
    Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition, 2015, Volume: 46, Issue:2

    Topics: 1-Naphthylamine; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Carcinoma, Hepatocellular; Cell Survival; DNA Damage; DNA Repair; Hep G2 Cells; Humans; Liver Neoplasms; Naphthalimides; Oxides; Quinolones

2015
The role of NF-κB in PARP-inhibitor-mediated sensitization and detoxification of arsenic trioxide in hepatocellular carcinoma cells.
    The Journal of toxicological sciences, 2015, Volume: 40, Issue:3

    Topics: 1-Naphthylamine; Acetylcysteine; Antineoplastic Agents; Antioxidants; Arsenic Trioxide; Arsenicals; Carcinoma, Hepatocellular; DNA Damage; Hep G2 Cells; Humans; Inactivation, Metabolic; Liver Neoplasms; Naphthalimides; NF-kappa B; Oxidative Stress; Oxides; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Poly(ADP-ribose) Polymerases; Quinolones; Reactive Oxygen Species

2015
Analysis of the transcriptional regulation of cancer-related genes by aberrant DNA methylation of the cis-regulation sites in the promoter region during hepatocyte carcinogenesis caused by arsenic.
    Oncotarget, 2015, Aug-28, Volume: 6, Issue:25

    Topics: Amino Acid Motifs; Arsenic Trioxide; Arsenicals; Basic Helix-Loop-Helix Leucine Zipper Transcription Factors; Carcinogenesis; Cell Line; Cell Transformation, Neoplastic; Computational Biology; DNA Methylation; Gene Expression Regulation, Neoplastic; Hepatocytes; Humans; Liver; Liver Neoplasms; Oligonucleotide Array Sequence Analysis; Oxides; Promoter Regions, Genetic; RNA, Messenger; Signal Transduction; Transcription Factors; Transcriptional Activation; Wnt Proteins

2015
Promyelocytic leukemia protein induces arsenic trioxide resistance through regulation of aldehyde dehydrogenase 3 family member A1 in hepatocellular carcinoma.
    Cancer letters, 2015, Sep-28, Volume: 366, Issue:1

    Topics: Adult; Aged; Aldehyde Dehydrogenase; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Carcinoma, Hepatocellular; Drug Resistance, Neoplasm; Female; Humans; Liver Neoplasms; Male; Middle Aged; Nuclear Proteins; Oxides; Promyelocytic Leukemia Protein; Transcription Factors; Tumor Suppressor Proteins

2015
Downregulation of B7-H4 in the MHCC97-H hepatocellular carcinoma cell line by arsenic trioxide.
    Molecular medicine reports, 2016, Volume: 13, Issue:3

    Topics: Arsenic Trioxide; Arsenicals; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Down-Regulation; Gene Expression Regulation, Neoplastic; Humans; Janus Kinase 2; Liver Neoplasms; Matrix Metalloproteinase 2; Neoplasm Invasiveness; Neoplasm Metastasis; Neovascularization, Pathologic; Oxides; RNA, Messenger; Signal Transduction; STAT3 Transcription Factor; V-Set Domain-Containing T-Cell Activation Inhibitor 1; Vascular Endothelial Growth Factor A

2016
A facile route to core-shell nanoparticulate formation of arsenic trioxide for effective solid tumor treatment.
    Nanoscale, 2016, Feb-21, Volume: 8, Issue:7

    Topics: Animals; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Survival; Drug Carriers; Drug Liberation; Female; Humans; Leukemia, Promyelocytic, Acute; Liver Neoplasms; Mice; Mice, Inbred ICR; Microscopy, Electron, Transmission; Nanoparticles; Oxides; Porosity; Silicon Dioxide; Surface Properties; Transplantation, Heterologous

2016
[Treatment of refractory pulmonary metastases from hepatocellular carcinoma by transcatheter arterial chemoembolization using arsenic trioxide in combination with sorafinib].
    Zhonghua zhong liu za zhi [Chinese journal of oncology], 2015, Volume: 37, Issue:12

    Topics: Antineoplastic Combined Chemotherapy Protocols; Arsenic Trioxide; Arsenicals; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Humans; Liver Neoplasms; Lung Neoplasms; Niacinamide; Oxides; Phenylurea Compounds; Sorafenib

2015
Inorganic phosphate-triggered release of anti-cancer arsenic trioxide from a self-delivery system: an in vitro and in vivo study.
    Nanoscale, 2016, Mar-21, Volume: 8, Issue:11

    Topics: Animals; Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Cell Line, Tumor; Cell Movement; Dextrans; Drug Delivery Systems; Female; Hep G2 Cells; Humans; Kinetics; Liver Neoplasms; Mice; Microscopy, Electron, Transmission; Nanoparticles; Neoplasm Invasiveness; Neoplasm Transplantation; Oxides; Phosphates; Rats; Spectroscopy, Fourier Transform Infrared; Thermodynamics

2016
[The Experiment Study and Mechanism of Aspirin Enhances Cellular Sensitivity of Hepatocellular Carcinoma Cell Line to Arsenic Trioxide].
    Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition, 2016, Volume: 47, Issue:2

    Topics: Apoptosis; Arsenic Trioxide; Arsenicals; Aspirin; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Survival; Drug Resistance, Neoplasm; Flow Cytometry; Heme Oxygenase-1; Humans; Liver Neoplasms; NF-E2-Related Factor 2; Oxides; Reactive Oxygen Species

2016
Shikonin potentiates the effect of arsenic trioxide against human hepatocellular carcinoma in vitro and in vivo.
    Oncotarget, 2016, Oct-25, Volume: 7, Issue:43

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Arsenic Trioxide; Arsenicals; Carcinoma, Hepatocellular; Cell Line; Cell Line, Tumor; DNA Damage; Drug Synergism; Endoplasmic Reticulum Stress; Hep G2 Cells; Humans; Liver Neoplasms; Mice, Nude; Naphthoquinones; Oxides; Xenograft Model Antitumor Assays

2016
microRNA-539 suppresses tumor growth and tumorigenesis and overcomes arsenic trioxide resistance in hepatocellular carcinoma.
    Life sciences, 2016, Dec-01, Volume: 166

    Topics: Animals; Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Carcinogenesis; Carcinoma, Hepatocellular; Cell Line, Tumor; Drug Resistance, Neoplasm; Gene Expression Regulation, Neoplastic; Genes, Tumor Suppressor; Hep G2 Cells; Humans; Liver; Liver Neoplasms; Male; Mice, Nude; MicroRNAs; Oxides

2016
Arsenic trioxide is an immune adjuvant in liver cancer treatment.
    Molecular immunology, 2017, Volume: 81

    Topics: Adjuvants, Immunologic; Animals; Arsenic Trioxide; Arsenicals; Carcinoma, Hepatocellular; Cytokine-Induced Killer Cells; Enzyme-Linked Immunosorbent Assay; Flow Cytometry; Fluorescent Antibody Technique; Humans; Liver Neoplasms; Lymphocytes, Tumor-Infiltrating; Male; Mice; Oxides; Real-Time Polymerase Chain Reaction; T-Lymphocytes; Xenograft Model Antitumor Assays

2017
Realgar transforming solution displays anticancer potential against human hepatocellular carcinoma HepG2 cells by inducing ROS.
    International journal of oncology, 2017, Volume: 50, Issue:2

    Topics: Acidithiobacillus; Antineoplastic Agents; Apoptosis; Arsenicals; Biodegradation, Environmental; Carcinoma, Hepatocellular; Cell Proliferation; Cell Survival; G2 Phase Cell Cycle Checkpoints; Gene Expression Regulation, Neoplastic; Hep G2 Cells; Humans; Liver Neoplasms; Medicine, Chinese Traditional; Reactive Oxygen Species; Sulfides

2017
RGD conjugated liposome-hollow silica hybrid nanovehicles for targeted and controlled delivery of arsenic trioxide against hepatic carcinoma.
    International journal of pharmaceutics, 2017, Mar-15, Volume: 519, Issue:1-2

    Topics: Animals; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Carcinoma, Hepatocellular; Delayed-Action Preparations; Drug Carriers; Drug Delivery Systems; Hep G2 Cells; Humans; Hydrogen-Ion Concentration; Liposomes; Liver Neoplasms; MCF-7 Cells; Mice; Nanoparticles; Oligopeptides; Oxides; Silicon Dioxide

2017
Periostin contributes to arsenic trioxide resistance in hepatocellular carcinoma cells under hypoxia.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2017, Volume: 88

    Topics: Animals; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Carcinoma, Hepatocellular; Caspase 3; Cell Adhesion Molecules; Cell Line, Tumor; Drug Resistance, Neoplasm; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Liver Neoplasms; Male; Mice; Mice, Inbred BALB C; Oxides; Tumor Microenvironment; Xenograft Model Antitumor Assays

2017
Cryptotanshinone enhances the effect of Arsenic trioxide in treating liver cancer cell by inducing apoptosis through downregulating phosphorylated- STAT3 in vitro and in vivo.
    BMC complementary and alternative medicine, 2017, Feb-10, Volume: 17, Issue:1

    Topics: Animals; Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Cell Line, Tumor; Cell Survival; Down-Regulation; Humans; Liver Neoplasms; Male; Mice; Mice, Inbred BALB C; Oxides; Phenanthrenes; Phosphorylation; STAT3 Transcription Factor; Xenograft Model Antitumor Assays

2017
Arsenic trioxide-induced growth arrest of human hepatocellular carcinoma cells involving FOXO3a expression and localization.
    Medical oncology (Northwood, London, England), 2009, Volume: 26, Issue:2

    Topics: Androstadienes; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Cell Survival; Forkhead Box Protein O3; Forkhead Transcription Factors; Humans; Liver Neoplasms; Metabolic Networks and Pathways; Oxides; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Wortmannin

2009
Possible roles of a tumor suppressor gene PIG11 in hepatocarcinogenesis and As2O3-induced apoptosis in liver cancer cells.
    Journal of gastroenterology, 2009, Volume: 44, Issue:5

    Topics: Adult; Apoptosis; Arsenic Trioxide; Arsenicals; Carcinoma, Hepatocellular; Cell Line, Tumor; Child; Cycloheximide; Dactinomycin; Down-Regulation; Female; Gene Expression; Gene Knockdown Techniques; Genes, Tumor Suppressor; Humans; Immunohistochemistry; Liver; Liver Neoplasms; Male; Middle Aged; Neoplasm Proteins; Nucleic Acid Synthesis Inhibitors; Oxides; Protein Synthesis Inhibitors

2009
Structure-effect relationship in the down-regulation of glutaminase in cultured human cells by phenylarsenic compounds.
    Toxicology, 2009, Apr-28, Volume: 258, Issue:2-3

    Topics: Arsenicals; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Survival; Dose-Response Relationship, Drug; Down-Regulation; Glutaminase; Hepatocytes; Humans; Liver Neoplasms; Molecular Structure; Time Factors

2009
The overexpression of multidrug resistance-associated proteins and gankyrin contribute to arsenic trioxide resistance in liver and gastric cancer cells.
    Oncology reports, 2009, Volume: 22, Issue:1

    Topics: Antineoplastic Agents; Arsenic Trioxide; Arsenicals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Line, Tumor; Cell Survival; Drug Resistance, Neoplasm; Humans; Liver Neoplasms; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Oxides; Phosphorylation; Proteasome Endopeptidase Complex; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-mdm2; Retinoblastoma Protein; Stomach Neoplasms; Time Factors; Tumor Suppressor Protein p53; Up-Regulation; Verapamil

2009
Nanosized As2O3/Fe2O3 complexes combined with magnetic fluid hyperthermia selectively target liver cancer cells.
    World journal of gastroenterology, 2009, Jun-28, Volume: 15, Issue:24

    Topics: Animals; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Biocompatible Materials; Cell Line, Tumor; Female; Ferric Compounds; Humans; Hyperthermia, Induced; Liver Neoplasms; Magnetics; Male; Materials Testing; Medicine, Chinese Traditional; Mice; Mice, Nude; Nanospheres; Oxides; Random Allocation; Swine; Transplantation, Heterologous

2009
Arsenic trioxide inhibits metastatic potential of mouse hepatoma H22 cells in vitro and in vivo.
    Hepatobiliary & pancreatic diseases international : HBPD INT, 2009, Volume: 8, Issue:5

    Topics: Animals; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Carcinoma, Hepatocellular; Cell Adhesion; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Disease Models, Animal; Dose-Response Relationship, Drug; Liver Neoplasms; Lung Neoplasms; Male; Matrix Metalloproteinase 2; Mice; NM23 Nucleoside Diphosphate Kinases; Oxides; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization

2009
Genistein synergizes with arsenic trioxide to suppress human hepatocellular carcinoma.
    Cancer science, 2010, Volume: 101, Issue:4

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Arsenic Trioxide; Arsenicals; Carcinoma, Hepatocellular; Caspase 9; Cell Line, Tumor; Cell Survival; Drug Synergism; Genistein; Humans; Liver Neoplasms; Male; Mice; Mice, Nude; Oxides; Reactive Oxygen Species; Xenograft Model Antitumor Assays

2010
Genistein potentiates the effect of arsenic trioxide against human hepatocellular carcinoma: role of Akt and nuclear factor-κB.
    Cancer letters, 2011, Feb-01, Volume: 301, Issue:1

    Topics: Animals; Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Carcinoma, Hepatocellular; Cell Cycle; Cell Proliferation; Drug Synergism; Genistein; Hep G2 Cells; Humans; Liver Neoplasms; Mice; NF-kappa B; Oxides; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Xenograft Model Antitumor Assays

2011
microRNA expression alteration after arsenic trioxide treatment in HepG-2 cells.
    Journal of gastroenterology and hepatology, 2011, Volume: 26, Issue:1

    Topics: Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Blotting, Western; Carcinoma, Hepatocellular; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Flow Cytometry; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Genes, Reporter; Hep G2 Cells; Humans; Liver Neoplasms; MicroRNAs; Oligonucleotide Array Sequence Analysis; Oxides; Phosphoprotein Phosphatases; Protein Phosphatase 2C; Reverse Transcriptase Polymerase Chain Reaction; Transfection

2011
Normoxically overexpressed hypoxia inducible factor 1-alpha is involved in arsenic trioxide resistance acquisition in hepatocellular carcinoma.
    Annals of surgical oncology, 2011, Volume: 18, Issue:5

    Topics: Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Blotting, Western; Carcinoma, Hepatocellular; Caspase 3; Caspase 7; Cell Cycle; Cell Proliferation; Drug Resistance, Neoplasm; Endoplasmic Reticulum Chaperone BiP; Enzyme Activation; Enzyme-Linked Immunosorbent Assay; Flow Cytometry; Heat-Shock Proteins; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Lipid Peroxidation; Liver Neoplasms; Membrane Potential, Mitochondrial; Nitric Oxide; Oxides; Oxygen; Reactive Oxygen Species; Tumor Cells, Cultured

2011
Combination of Poly I:C and arsenic trioxide triggers apoptosis synergistically via activation of TLR3 and mitochondrial pathways in hepatocellular carcinoma cells.
    Cell biology international, 2011, Volume: 35, Issue:8

    Topics: Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; bcl-2-Associated X Protein; BH3 Interacting Domain Death Agonist Protein; Carcinoma, Hepatocellular; Caspase 3; Caspase 8; Caspase 9; Cell Line, Tumor; Cell Proliferation; Drug Synergism; Drug Therapy, Combination; Humans; Inhibitor of Apoptosis Proteins; Interferon Inducers; Liver Neoplasms; Mitochondria; Oxides; Poly I-C; Polymerase Chain Reaction; Proto-Oncogene Proteins c-bcl-2; Reactive Oxygen Species; Survivin; Toll-Like Receptor 3

2011
[Anti-angiogenesis effect of arsenic trioxide plus cinobufacin on human hepatocarcinoma transplantation model nude mice].
    Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine, 2011, Volume: 31, Issue:1

    Topics: Amphibian Venoms; Angiogenesis Inhibitors; Animals; Antineoplastic Combined Chemotherapy Protocols; Arsenic Trioxide; Arsenicals; Carcinoma, Hepatocellular; Cell Line, Tumor; Drug Synergism; Humans; Liver Neoplasms; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Neovascularization, Pathologic; Oxides; Phytotherapy; Xenograft Model Antitumor Assays

2011
Arterial embolization hyperthermia using As2O3 nanoparticles in VX2 carcinoma-induced liver tumors.
    PloS one, 2011, Mar-23, Volume: 6, Issue:3

    Topics: Angiography; Animals; Arsenic Trioxide; Arsenicals; Embolization, Therapeutic; Hyperthermia, Induced; Immunohistochemistry; Liver; Liver Function Tests; Liver Neoplasms; Male; Microvessels; Nanoparticles; Necrosis; Oxides; Platelet Endothelial Cell Adhesion Molecule-1; Rabbits; Survival Analysis; Temperature; Tomography, X-Ray Computed; Treatment Outcome; Vascular Endothelial Growth Factor A

2011
Synergic effect of 3'-azido-3'-deoxythymidine and arsenic trioxide in suppressing hepatoma cells.
    Anti-cancer drugs, 2011, Volume: 22, Issue:5

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Antitubercular Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Carcinoma, Hepatocellular; Caspase 3; Cell Growth Processes; Cell Survival; Dose-Response Relationship, Drug; Drug Synergism; Hep G2 Cells; Humans; Liver Neoplasms; Mice; Mice, Inbred BALB C; Oxides; Telomerase; Xenograft Model Antitumor Assays; Zidovudine

2011
Pharmacokinetics of arsenic trioxide (As₂O₃) in Chinese primary hepatocarcinoma patients.
    Asian Pacific journal of cancer prevention : APJCP, 2011, Volume: 12, Issue:1

    Topics: Area Under Curve; Arsenic Trioxide; Arsenicals; Asian People; Carcinoma, Hepatocellular; Female; Half-Life; Humans; Injections, Intravenous; Liver Neoplasms; Male; Middle Aged; Oxides

2011
Suppression of TG-interacting factor sensitizes arsenic trioxide-induced apoptosis in human hepatocellular carcinoma cells.
    The Biochemical journal, 2011, Sep-01, Volume: 438, Issue:2

    Topics: 3' Untranslated Regions; Antigens, Surface; Apoptosis; Arsenic Trioxide; Arsenicals; Carcinoma, Hepatocellular; Cell Line, Tumor; Cyclin-Dependent Kinase Inhibitor p21; ELAV Proteins; ELAV-Like Protein 1; ErbB Receptors; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; Homeodomain Proteins; Humans; Liver Neoplasms; Models, Biological; Oxides; Phosphatidylinositol 3-Kinases; Repressor Proteins; RNA Stability; RNA-Binding Proteins; RNA, Messenger; Signal Transduction; Transcription, Genetic; Transforming Growth Factor beta

2011
Arsenic trioxide plus cisplatin/interferon α-2b/doxorubicin/capecitabine combination chemotherapy for unresectable hepatocellular carcinoma.
    Hematology/oncology and stem cell therapy, 2011, Volume: 4, Issue:2

    Topics: AC133 Antigen; Antigens, CD; Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Capecitabine; Carcinoma, Hepatocellular; Cell Line; Cisplatin; Deoxycytidine; Doxorubicin; Drug Resistance, Neoplasm; Fluorescent Dyes; Fluorouracil; Glycoproteins; Hep G2 Cells; Humans; Immunohistochemistry; Interferon-alpha; Liver Neoplasms; Oxides; Peptides; Rhodamine 123; Thy-1 Antigens

2011
Arsenic trioxide inhibits HCCLM3 cells invasion through de novo ceramide synthesis and sphingomyelinase-induced ceramide production.
    Medical oncology (Northwood, London, England), 2012, Volume: 29, Issue:3

    Topics: Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Blotting, Western; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Movement; Ceramides; Humans; Liver Neoplasms; Matrix Metalloproteinase 9; Microscopy, Fluorescence; Neoplasm Invasiveness; Oxides; Sphingomyelin Phosphodiesterase

2012
Synergistic antitumor activity of oridonin and arsenic trioxide on hepatocellular carcinoma cells.
    International journal of oncology, 2012, Volume: 40, Issue:1

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Arsenic Trioxide; Arsenicals; Carcinoma, Hepatocellular; Cell Line, Tumor; Diterpenes, Kaurane; Drug Synergism; Female; Humans; Liver Neoplasms; Liver Neoplasms, Experimental; Membrane Potential, Mitochondrial; Mice; Mice, Inbred C57BL; Mitogen-Activated Protein Kinases; Neoplasm Transplantation; NF-kappa B; Oxides; Proto-Oncogene Proteins c-akt; Reactive Oxygen Species; X-Linked Inhibitor of Apoptosis Protein

2012
Antiproliferative effect of novel platinum(II) and palladium(II) complexes on hepatic tumor stem cells in vitro.
    European journal of medicinal chemistry, 2012, Volume: 49

    Topics: Antineoplastic Agents; Arsenicals; Cell Line; Cell Line, Tumor; Cell Proliferation; Crystallography, X-Ray; DNA Damage; Hep G2 Cells; Hepatocytes; Humans; Liver Neoplasms; Models, Molecular; Neoplastic Stem Cells; Organoplatinum Compounds; Palladium

2012
Tumors and proliferative lesions in adult offspring after maternal exposure to methylarsonous acid during gestation in CD1 mice.
    Archives of toxicology, 2012, Volume: 86, Issue:6

    Topics: Adenocarcinoma; Adenoma; Adrenal Gland Neoplasms; Animals; Arsenic; Arsenicals; Carcinogens; Carcinoma, Hepatocellular; Dose-Response Relationship, Drug; Female; Liver Neoplasms; Lung Neoplasms; Male; Maternal Exposure; Mice; Neoplasms; Ovarian Neoplasms; Pregnancy; Pregnancy Complications, Neoplastic; Prenatal Exposure Delayed Effects; Testicular Neoplasms; Uterine Neoplasms

2012
Arsenic trioxide induces G2/M arrest in hepatocellular carcinoma cells by increasing the tumor suppressor PTEN expression.
    Journal of cellular biochemistry, 2012, Volume: 113, Issue:11

    Topics: Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Carcinoma, Hepatocellular; CDC2 Protein Kinase; Cell Cycle Proteins; Cell Line, Tumor; Cyclin B; Cyclin-Dependent Kinases; Dose-Response Relationship, Drug; G2 Phase Cell Cycle Checkpoints; Gene Expression Regulation, Neoplastic; Humans; Liver Neoplasms; Nuclear Proteins; Oxides; Phosphorylation; Protein-Tyrosine Kinases; Proto-Oncogene Proteins c-akt; PTEN Phosphohydrolase; RNA, Small Interfering; Signal Transduction

2012
Differential effects of arsenic trioxide on chemosensitization in human hepatic tumor and stellate cell lines.
    BMC cancer, 2012, Sep-10, Volume: 12

    Topics: Adult; AMP-Activated Protein Kinases; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Blotting, Western; Carcinoma, Hepatocellular; Cell Line; Cell Proliferation; Cell Survival; Drug Synergism; Enzyme Activation; Fluorouracil; Gene Expression Regulation, Enzymologic; Growth Inhibitors; Hep G2 Cells; Hepatic Stellate Cells; Humans; Inhibitory Concentration 50; Liver Neoplasms; Niacinamide; Oxides; Phenylurea Compounds; Reverse Transcriptase Polymerase Chain Reaction; Sorafenib; Thymidylate Synthase; Time Factors

2012
[Inhibitory effect of arsenic trioxide on invasion in human hepatocellular carcinoma SMMC-7721 cells and its mechanism].
    Xi bao yu fen zi mian yi xue za zhi = Chinese journal of cellular and molecular immunology, 2012, Volume: 28, Issue:12

    Topics: Arsenic Trioxide; Arsenicals; Basigin; Carcinoma, Hepatocellular; Cell Line, Tumor; Down-Regulation; Gene Expression Regulation, Neoplastic; Humans; Liver Neoplasms; Matrix Metalloproteinase 2; Neoplasm Invasiveness; Oxides

2012
[Comparison of antitumor efficacy between arsacetyl and arsenic trioxide in vitro].
    Ai zheng = Aizheng = Chinese journal of cancer, 2002, Volume: 21, Issue:4

    Topics: Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Carcinoma, Hepatocellular; DNA Fragmentation; Drug Screening Assays, Antitumor; Endothelium, Vascular; Flow Cytometry; G1 Phase; Humans; Inhibitory Concentration 50; Liver Neoplasms; Oxides; Resting Phase, Cell Cycle; Tumor Cells, Cultured

2002
Blockage of multidrug resistance-associated proteins potentiates the inhibitory effects of arsenic trioxide on CYP1A1 induction by polycyclic aromatic hydrocarbons.
    The Journal of pharmacology and experimental therapeutics, 2003, Volume: 304, Issue:1

    Topics: Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Blotting, Western; Carcinogens; Carcinoma, Hepatocellular; Cell Survival; Cytochrome P-450 CYP1A1; Dioxins; Drug Synergism; Enzyme Induction; Genes, Reporter; Hepatocytes; Humans; Immunoblotting; In Vitro Techniques; Liver Neoplasms; Mitochondrial Proteins; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Oxides; Polycyclic Aromatic Hydrocarbons; Protein Processing, Post-Translational; Reactive Oxygen Species; Ribosomal Proteins; RNA, Messenger; Saccharomyces cerevisiae Proteins; Transcription, Genetic; Tumor Cells, Cultured

2003
Synergistic effect of cell differential agent-II and arsenic trioxide on induction of cell cycle arrest and apoptosis in hepatoma cells.
    World journal of gastroenterology, 2003, Volume: 9, Issue:1

    Topics: Apoptosis; Arsenic Trioxide; Arsenicals; Carcinoma, Hepatocellular; Cell Cycle; Cell Survival; Flow Cytometry; Growth Inhibitors; Humans; Liver Neoplasms; Oxides; Tumor Cells, Cultured

2003
Methylated metabolites of arsenic trioxide are more potent than arsenic trioxide as apoptotic but not differentiation inducers in leukemia and lymphoma cells.
    Cancer research, 2003, Apr-15, Volume: 63, Issue:8

    Topics: Apoptosis; Arsenic Trioxide; Arsenicals; Carcinoma, Hepatocellular; Cell Differentiation; Coculture Techniques; Glutathione Peroxidase; Hematopoietic Stem Cells; Humans; Hydrogen Peroxide; K562 Cells; Leukemia, Promyelocytic, Acute; Liver Neoplasms; Lymphoma; Methylation; Neoplasm Proteins; Oncogene Proteins, Fusion; Oxides; Tumor Cells, Cultured

2003
Arsenic trioxide induces apoptosis of rat hepatocellular carcinoma cells in vivo.
    Journal of experimental & clinical cancer research : CR, 2003, Volume: 22, Issue:1

    Topics: Animals; Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Carcinoma, Hepatocellular; Cell Cycle; Female; Liver Neoplasms; Male; Microscopy, Electron; Oxides; Rats; Rats, Wistar; Tumor Cells, Cultured

2003
[Mechanism of arsenic trioxide-induced apoptosis in hepatic blastoma cells HepG2].
    Zhonghua zhong liu za zhi [Chinese journal of oncology], 2003, Volume: 25, Issue:2

    Topics: Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Hep G2 Cells; Hepatoblastoma; Humans; Liver Neoplasms; Nuclear Proteins; Oxides; Promyelocytic Leukemia Protein; Transcription Factors; Tumor Suppressor Proteins

2003
A case of cirrhosis and primary carcinoma of the liver in chronic industrial arsenical intoxication.
    British journal of industrial medicine, 1959, Volume: 16

    Topics: Arsenicals; Carcinoma; Humans; Liver Cirrhosis; Liver Neoplasms; Medical Records

1959
Antitumor effect of arsenic trioxide in murine xenograft model.
    Cancer science, 2003, Volume: 94, Issue:11

    Topics: Animals; Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Brain; Carcinoma, Hepatocellular; Humans; In Situ Nick-End Labeling; Injections, Intravenous; Kidney; Liver; Liver Neoplasms; Male; Mice; Mice, Inbred BALB C; Oxides; Spectrometry, X-Ray Emission; Transplantation, Heterologous; Tumor Cells, Cultured

2003
Arsenic trioxide-induced transcriptional activation of stress genes and expression of related proteins in human liver carcinoma cells (HepG2).
    Cellular and molecular biology (Noisy-le-Grand, France), 2003, Volume: 49, Issue:7

    Topics: Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Cell Survival; Cloning, Molecular; Gene Expression Regulation, Neoplastic; Genes, Reporter; HSP70 Heat-Shock Proteins; Humans; Liver Neoplasms; Metallothionein; Oxides; Promoter Regions, Genetic; Proto-Oncogene Proteins c-fos; Transcriptional Activation; Tumor Cells, Cultured; Tumor Suppressor Protein p53

2003
[Application of arsenic trioxide in comprehensive therapy of liver carcinoma].
    Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine, 2003, Volume: 23, Issue:12

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Arsenic Trioxide; Arsenicals; Carcinoma, Hepatocellular; Cisplatin; Doxorubicin; Female; Fluorouracil; Humans; Liver Neoplasms; Male; Middle Aged; Oxides

2003
Radiofrequency ablation: Effect of pharmacologic modulation of hepatic and renal blood flow on coagulation diameter in a VX2 tumor model.
    Journal of vascular and interventional radiology : JVIR, 2004, Volume: 15, Issue:3

    Topics: Adrenergic Agonists; Anesthetics, Inhalation; Animals; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Carcinoma; Catheter Ablation; Disease Models, Animal; Epinephrine; Halothane; Kidney; Kidney Neoplasms; Laser-Doppler Flowmetry; Liver; Liver Neoplasms; Oxides; Rabbits; Regional Blood Flow

2004
[Study on effect of arsenic trioxide on adhesion and invasion of human hepatocarcinoma cells in vitro].
    Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine, 2004, Volume: 24, Issue:10

    Topics: Animals; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Carcinoma, Hepatocellular; Cell Adhesion; Cell Line, Tumor; Cell Movement; Humans; Hyaluronan Receptors; Intercellular Adhesion Molecule-1; Liver Neoplasms; Matrix Metalloproteinase 2; Mice; Mice, Nude; Neoplasm Invasiveness; Oxides

2004
[The effect and mechanism of arsenic trioxide on hepatocellular carcinoma].
    Zhonghua wai ke za zhi [Chinese journal of surgery], 2005, Jan-01, Volume: 43, Issue:1

    Topics: Adult; Aged; Animals; Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Carcinoma, Hepatocellular; Cell Line, Tumor; Chemotherapy, Cancer, Regional Perfusion; Female; Humans; Liver Neoplasms; Liver Neoplasms, Experimental; Male; Mice; Mice, Nude; Middle Aged; Oxides

2005
Arsenic trioxide synergizes with B7H3-mediated immunotherapy to eradicate hepatocellular carcinomas.
    International journal of cancer, 2006, Apr-01, Volume: 118, Issue:7

    Topics: Animals; Antigens, CD; Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; B7 Antigens; B7-1 Antigen; Carcinoma, Hepatocellular; Combined Modality Therapy; Gene Transfer Techniques; Humans; Immunotherapy; Interferon-gamma; Liver Neoplasms; Male; Mice; Mice, Inbred BALB C; Oxides; Receptors, Immunologic; T-Lymphocytes, Cytotoxic

2006
Arsenic trioxide inhibits DNA methyltransferase and restores methylation-silenced genes in human liver cancer cells.
    Human pathology, 2006, Volume: 37, Issue:3

    Topics: Aged; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Cadherins; Carcinoma, Hepatocellular; Cell Line, Tumor; DNA (Cytosine-5-)-Methyltransferases; DNA Methylation; Dose-Response Relationship, Drug; Enzyme Inhibitors; Female; Gene Expression Regulation, Neoplastic; Gene Silencing; Genes, Neoplasm; Genes, p16; Glutathione S-Transferase pi; Hepatocytes; Humans; Liver Neoplasms; Male; Middle Aged; Oxides; RNA, Messenger; Tumor Suppressor Proteins

2006
Role of oxidative stress in the apoptosis of hepatocellular carcinoma induced by combination of arsenic trioxide and ascorbic acid.
    Acta pharmacologica Sinica, 2006, Volume: 27, Issue:8

    Topics: Acetylcysteine; Antineoplastic Agents; Antioxidants; Apoptosis; Arsenic Trioxide; Arsenicals; Ascorbic Acid; bcl-2-Associated X Protein; Carcinoma, Hepatocellular; Cell Line, Tumor; Drug Synergism; Free Radical Scavengers; Humans; Liver Neoplasms; Oxidative Stress; Oxides; Proto-Oncogene Proteins c-bcl-2

2006
Dithiothreitol abrogates the effect of arsenic trioxide on normal rat liver mitochondria and human hepatocellular carcinoma cells.
    Toxicology and applied pharmacology, 2008, Jan-15, Volume: 226, Issue:2

    Topics: Animals; Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Carcinoma, Hepatocellular; Cell Line, Tumor; Dithiothreitol; Dose-Response Relationship, Drug; Electron Transport Chain Complex Proteins; Environmental Pollutants; Humans; Liver Neoplasms; Male; Membrane Potential, Mitochondrial; Mitochondria, Liver; Oxides; Oxygen Consumption; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species

2008
[Inhibitory effect of arsenic trioxide on proliferation of human hepatocellular carcinoma cell line SMMC-7721 and the mechanism].
    Ai zheng = Aizheng = Chinese journal of cancer, 2007, Volume: 26, Issue:12

    Topics: Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Nucleus; Cell Proliferation; COP9 Signalosome Complex; Cyclin-Dependent Kinase Inhibitor p27; Cytoplasm; Humans; Intracellular Signaling Peptides and Proteins; Liver Neoplasms; Oxides; Peptide Hydrolases

2007
Redox status of thioredoxin-1 (TRX1) determines the sensitivity of human liver carcinoma cells (HepG2) to arsenic trioxide-induced cell death.
    Cell research, 2008, Volume: 18, Issue:4

    Topics: Animals; Arsenic Trioxide; Arsenicals; Binding Sites; Carcinoma, Hepatocellular; Caspases; Cell Death; Cell Line, Tumor; Cytochromes c; Dinitrochlorobenzene; Drug Screening Assays, Antitumor; Enzyme Activation; Humans; Liver Neoplasms; Mice; Mitochondria; Mitochondrial Swelling; Mutant Proteins; NADP; Oxidation-Reduction; Oxides; Reactive Oxygen Species; Recombinant Proteins; RNA Interference; Thioredoxins

2008
[Inhibitory effect of sorafenib combined with arsenic trioxide on hepatocellular carcinoma cells].
    Nan fang yi ke da xue xue bao = Journal of Southern Medical University, 2008, Volume: 28, Issue:4

    Topics: Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Benzenesulfonates; Blotting, Western; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Cell Survival; Drug Synergism; Extracellular Signal-Regulated MAP Kinases; Flow Cytometry; Humans; Liver Neoplasms; Membrane Potential, Mitochondrial; Niacinamide; Oxides; Phenylurea Compounds; Pyridines; Sorafenib

2008
Hepatic angiosarcoma associated with short-term arsenic ingestion.
    The American journal of medicine, 1982, Volume: 73, Issue:6

    Topics: Arsenic; Arsenicals; Carcinoma, Basal Cell; Hemangiosarcoma; Humans; Liver Neoplasms; Male; Middle Aged; Skin Neoplasms; Time Factors

1982
Influence of vinyl chloride monomer (VCM) and As2O3 on rat liver cell proliferation after partial hepatectomy.
    Journal of cancer research and clinical oncology, 1980, Volume: 97, Issue:1

    Topics: Alkaline Phosphatase; Animals; Arsenic; Arsenic Trioxide; Arsenicals; Dose-Response Relationship, Drug; Hepatectomy; Liver; Liver Neoplasms; Liver Regeneration; Male; Mitosis; Oxides; Rats; Vinyl Chloride; Vinyl Compounds

1980
Cross-resistance to methotrexate and metals in human cisplatin-resistant cell lines results from a pleiotropic defect in accumulation of these compounds associated with reduced plasma membrane binding proteins.
    Cancer research, 1998, Jan-15, Volume: 58, Issue:2

    Topics: Antineoplastic Agents; Arsenicals; Blotting, Northern; Carcinoma, Squamous Cell; Carrier Proteins; Cell Membrane; Cisplatin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Fluorescent Antibody Technique, Indirect; Folate Receptors, GPI-Anchored; Humans; Liver Neoplasms; Membrane Proteins; Metals; Methotrexate; Neoplasm Proteins; Receptors, Cell Surface; Tumor Cells, Cultured

1998
[An experimental study on arsenic trioxide-selectively induced human hepatocarcinoma cell lines apoptosis and its related genes].
    Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology, 2000, Volume: 8, Issue:6

    Topics: Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; bcl-2-Associated X Protein; Carcinoma, Hepatocellular; fas Receptor; Genes, bcl-2; Humans; In Situ Nick-End Labeling; Liver Neoplasms; Oxides; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; S Phase; Tumor Cells, Cultured

2000
Atrazine potentiation of arsenic trioxide-induced cytotoxicity and gene expression in human liver carcinoma cells (HepG2).
    Molecular and cellular biochemistry, 2001, Volume: 222, Issue:1-2

    Topics: Arsenic Trioxide; Arsenicals; Atrazine; Cell Line, Transformed; Cell Survival; Cyclic AMP Response Element-Binding Protein; Drug Synergism; Endoplasmic Reticulum Chaperone BiP; Gene Expression; Gene Expression Profiling; Hepatocytes; HSP70 Heat-Shock Proteins; Humans; Liver Neoplasms; Metallothionein; Oxides; Proto-Oncogene Proteins c-fos

2001
[Arsenic trioxide in the treatment of advanced primary liver and gallbladder cancer].
    Zhonghua zhong liu za zhi [Chinese journal of oncology], 2001, Volume: 23, Issue:6

    Topics: Adult; Aged; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Female; Gallbladder Neoplasms; Humans; Injections, Intravenous; Liver Neoplasms; Male; Middle Aged; Neoplasm Staging; Oxides; Quality of Life; Treatment Outcome

2001
Arsenic trioxide-induced apoptosis and its enhancement by buthionine sulfoximine in hepatocellular carcinoma cell lines.
    Biochemical and biophysical research communications, 2002, Mar-08, Volume: 291, Issue:4

    Topics: Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Buthionine Sulfoximine; Carcinoma, Hepatocellular; Caspases; Cell Division; Cell Nucleus; DNA Fragmentation; DNA, Neoplasm; Dose-Response Relationship, Drug; Drug Synergism; Glutathione; Humans; Kinetics; Liver Neoplasms; Oxides; Reactive Oxygen Species; Tumor Cells, Cultured

2002
Effect of arsenic trioxide on human hepatocellular carcinoma HepG2 cells: inhibition of proliferation and induction of apoptosis.
    Life sciences, 2002, Jun-07, Volume: 71, Issue:3

    Topics: Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Carcinoma, Hepatocellular; Caspase 3; Caspases; Cell Cycle; Cell Division; Enzyme Activation; Humans; Liver Neoplasms; Mitochondria; Oxides; Tumor Cells, Cultured

2002
Vinyl chloride-associated liver disease.
    Annals of internal medicine, 1976, Volume: 84, Issue:6

    Topics: Adult; Animals; Arsenicals; Chemical and Drug Induced Liver Injury; Epidemiologic Methods; Hemangiosarcoma; Humans; Liver Cirrhosis; Liver Diseases; Liver Function Tests; Liver Neoplasms; Male; Occupational Diseases; Polymers; Radionuclide Imaging; Rats; Thorium Dioxide; Time Factors; Vinyl Chloride; Vinyl Compounds

1976
Liver biopsy in psoriatics previously treated with potassium arsenite. A controlled study.
    Acta dermato-venereologica, 1974, Volume: 54, Issue:3

    Topics: Arsenicals; Biopsy; Chemical and Drug Induced Liver Injury; Humans; Liver; Liver Diseases; Liver Neoplasms; Male; Microscopy, Electron; Psoriasis

1974
Inhibition of cellular adhesiveness by sulfhydryl blocking agents.
    Journal of cellular physiology, 1971, Volume: 78, Issue:1

    Topics: Alkylating Agents; Animals; Arsenicals; Carcinoma, Hepatocellular; Cell Adhesion; Cell Line; Cells, Cultured; Culture Media; Culture Techniques; Dithiothreitol; Liver Neoplasms; Mercuribenzoates; Polystyrenes; Rats; Sulfhydryl Reagents; Time Factors

1971
In vitro estimate of sensitivity of individual human tumors to antitumor agents.
    Oncology, 1974, Volume: 30, Issue:1

    Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Arsenicals; Benzoates; Breast Neoplasms; Carbon Radioisotopes; Carcinoma; Carcinoma, Ehrlich Tumor; Cattle; Depression, Chemical; DNA, Neoplasm; Female; Fluorouracil; Humans; In Vitro Techniques; Iodoacetates; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Lymphoma, Non-Hodgkin; Mechlorethamine; Methotrexate; Mice; Neoplasms; Phenylalanine; Succinate Dehydrogenase; Thymidine; Tritium

1974
Significance of Inflammation and Apoptosis in Hepatocellular Death in Rat, Co-treated with Arsenic and Fluoride.
    Biological trace element research, 2022, Volume: 200, Issue:7

    Topics: Animals; Apoptosis; Arsenic; Body Weight; Carcinoma, Hepatocellular; Caspase 9; Female; Fluorides; Inflammation; Liver Neoplasms; Oxidative Stress; Rats; Rats, Wistar

2022
Augmented EPR effect post IRFA to enhance the therapeutic efficacy of arsenic loaded ZIF-8 nanoparticles on residual HCC progression.
    Journal of nanobiotechnology, 2022, Jan-15, Volume: 20, Issue:1

    Topics: Animals; Antineoplastic Agents; Arsenic; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Survival; Humans; Imidazoles; Liver Neoplasms; Metal-Organic Frameworks; Mice; Nanoparticles; Radiofrequency Ablation; Tissue Distribution

2022
The deubiquitinase USP7 regulates oxidative stress through stabilization of HO-1.
    Oncogene, 2022, Volume: 41, Issue:33

    Topics: Arsenic; Carcinoma, Hepatocellular; Heme Oxygenase-1; Humans; Liver Neoplasms; Oxidative Stress; Ubiquitin-Specific Peptidase 7

2022
Identification of therapeutic miRNAs from the arsenic induced gene expression profile of hepatocellular carcinoma.
    Chemical biology & drug design, 2023, Volume: 101, Issue:5

    Topics: Arsenic; Carcinoma, Hepatocellular; Gene Expression Regulation, Neoplastic; Humans; Liver Neoplasms; MicroRNAs; Transcriptome

2023
Inorganic arsenic exposure-induced premature senescence and senescence-associated secretory phenotype (SASP) in human hepatic stellate cells.
    Toxicology and applied pharmacology, 2022, 11-01, Volume: 454

    Topics: Arsenic; Arsenites; beta-Galactosidase; Cellular Senescence; Culture Media, Conditioned; DNA; Hepatic Stellate Cells; Humans; Interleukin-8; Liver Neoplasms; Matrix Metalloproteinase 1; Matrix Metalloproteinase 3; Phenotype; RNA, Messenger; Senescence-Associated Secretory Phenotype

2022
Arsenic-Loaded Biomimetic Iron Oxide Nanoparticles for Enhanced Ferroptosis-Inducing Therapy of Hepatocellular Carcinoma.
    ACS applied materials & interfaces, 2023, Feb-08, Volume: 15, Issue:5

    Topics: Animals; Antineoplastic Agents; Arsenic; Arsenic Trioxide; Biomimetics; Carcinoma, Hepatocellular; Cell Line, Tumor; Ferroptosis; Liver Neoplasms; Magnetic Iron Oxide Nanoparticles; Mice

2023
Effect of Long-Term Low-Dose Arsenic Exposure on DNA Methylation and Gene Expression in Human Liver Cells.
    International journal of molecular sciences, 2023, Oct-16, Volume: 24, Issue:20

    Topics: Arsenic; Arsenites; DNA; DNA (Cytosine-5-)-Methyltransferases; DNA Methylation; Gene Expression; Humans; Liver Neoplasms

2023
Race/ethnicity and sex differences in the association between area-level arsenic exposure concentration and hepatocellular carcinoma (HCC) incidence rates in Texas. An ecological study.
    Environmental research, 2024, Jan-01, Volume: 240, Issue:Pt 2

    Topics: Adult; Arsenic; Carcinoma, Hepatocellular; Ethnicity; Female; Humans; Incidence; Liver Neoplasms; Male; Receptors, Antigen, T-Cell; Sex Characteristics; Texas; Young Adult

2024
Effects of Selenium on Arsenic-Induced Liver Lesions in Broilers.
    Biological trace element research, 2021, Volume: 199, Issue:3

    Topics: Animals; Arsenic; Chickens; Liver; Liver Neoplasms; Male; Selenium

2021
Liposome-Coated Arsenic-Manganese Complex for Magnetic Resonance Imaging-Guided Synergistic Therapy Against Carcinoma.
    International journal of nanomedicine, 2021, Volume: 16

    Topics: Animals; Antineoplastic Agents; Apoptosis; Arsenic; Carcinoma, Hepatocellular; Cell Cycle; Drug Delivery Systems; Drug Synergism; Hep G2 Cells; Humans; Liposomes; Liver Neoplasms; Magnetic Resonance Imaging; Male; Manganese; Mice; Mice, Inbred BALB C; Mice, Nude; Xenograft Model Antitumor Assays

2021
Comparison of cytotoxicity and membrane efflux pump inhibition in HepG2 cells induced by single-walled carbon nanotubes with different length and functional groups.
    Scientific reports, 2019, 05-17, Volume: 9, Issue:1

    Topics: Arsenic; ATP-Binding Cassette Transporters; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Membrane; Cell Survival; Hep G2 Cells; Humans; Liver Neoplasms; Membrane Fluidity; Nanotubes, Carbon; Oxidative Stress; Reactive Oxygen Species

2019
Pyruvate Dehydrogenase Kinase 4 Deficiency Results in Expedited Cellular Proliferation through E2F1-Mediated Increase of Cyclins.
    Molecular pharmacology, 2017, Volume: 91, Issue:3

    Topics: Animals; Arsenic; Carcinoma, Hepatocellular; Cell Proliferation; Cyclins; Disease Progression; E2F1 Transcription Factor; Flow Cytometry; Hepatocytes; Liver; Liver Neoplasms; Male; Mice, Inbred C57BL; Protein Kinases; Sequence Analysis, RNA

2017
Increased childhood liver cancer mortality and arsenic in drinking water in northern Chile.
    Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2008, Volume: 17, Issue:8

    Topics: Adolescent; Arsenic; Child; Child, Preschool; Chile; Female; Humans; Infant; Infant, Newborn; Liver Neoplasms; Male; Poisson Distribution; Water Supply; Young Adult

2008
Arsenic-induced aberrant gene expression in fetal mouse primary liver-cell cultures.
    Annals of the New York Academy of Sciences, 2008, Volume: 1140

    Topics: Animals; Arsenic; Collagen; DNA Primers; Female; Gene Expression Profiling; Gene Expression Regulation; Liver; Liver Neoplasms; Mice; Oligonucleotide Array Sequence Analysis; Polymorphism, Genetic; Reverse Transcriptase Polymerase Chain Reaction

2008
[Effect of selenium and arsenic on oxidative stress, DNA oxidative damage and repair in HepG2 cells].
    Wei sheng yan jiu = Journal of hygiene research, 2008, Volume: 37, Issue:6

    Topics: 8-Hydroxy-2'-Deoxyguanosine; Arsenic; Carcinoma, Hepatocellular; Deoxyguanosine; DNA Damage; DNA Repair; Dose-Response Relationship, Drug; Drug Synergism; Hep G2 Cells; Humans; Liver Neoplasms; Malondialdehyde; Oxidative Stress; Selenium

2008
Efficacy of transarterial embolization with arsenic trioxide oil emulsion in a rabbit VX2 liver tumor model.
    Journal of vascular and interventional radiology : JVIR, 2009, Volume: 20, Issue:10

    Topics: Animals; Arsenic; Carcinoma, Hepatocellular; Cell Line, Tumor; Embolization, Therapeutic; Emulsions; Hemostatics; Humans; Iodized Oil; Liver; Liver Neoplasms; Rabbits; Treatment Outcome

2009
Identification of arsenite-and arsenic diglutathione-binding proteins in human hepatocarcinoma cells.
    Toxicology and applied pharmacology, 2010, Jan-15, Volume: 242, Issue:2

    Topics: Amino Acid Sequence; Arsenic; Arsenites; Cell Line, Tumor; Electrophoresis, Polyacrylamide Gel; Glutathione; Humans; Liver Neoplasms; Molecular Sequence Data; Neoplasm Proteins

2010
Comparative study of liver cancer patients in arsenic exposed and non-exposed areas of Pakistan.
    Biological trace element research, 2011, Volume: 144, Issue:1-3

    Topics: Adult; Aged; Arsenic; Calibration; Drinking Water; Environmental Exposure; Hair; Humans; Indicators and Reagents; Liver Neoplasms; Male; Maximum Allowable Concentration; Microwaves; Middle Aged; Pakistan; Spectrophotometry, Atomic; Water Pollutants, Chemical; Water Supply

2011
Renal, hepatic, pulmonary and adrenal tumors induced by prenatal inorganic arsenic followed by dimethylarsinic acid in adulthood in CD1 mice.
    Toxicology letters, 2012, Mar-07, Volume: 209, Issue:2

    Topics: Adrenal Gland Neoplasms; Animals; Arsenic; Cacodylic Acid; Female; Histocytochemistry; Kidney Neoplasms; Liver Neoplasms; Lung Neoplasms; Male; Mice; Pregnancy; Prenatal Exposure Delayed Effects; Random Allocation; Survival Analysis

2012
Increased serum level of epidermal growth factor receptor in liver cancer patients and its association with exposure to arsenic.
    The Science of the total environment, 2012, May-01, Volume: 424

    Topics: Adult; Aged; Arsenic; Biomarkers, Tumor; Carcinogens; Case-Control Studies; Environmental Exposure; Enzyme-Linked Immunosorbent Assay; ErbB Receptors; Female; Humans; Liver Neoplasms; Male; Middle Aged; Risk Factors; Taiwan

2012
Investigation of essential trace and toxic elements in biological samples (blood, serum and scalp hair) of liver cirrhotic/cancer female patients before and after mineral supplementation.
    Clinical nutrition (Edinburgh, Scotland), 2012, Volume: 31, Issue:6

    Topics: Adult; Arsenic; Case-Control Studies; Dietary Supplements; Female; Hair; Humans; Lead; Liver Cirrhosis; Liver Neoplasms; Middle Aged; Nickel; Scalp; Selenium; Trace Elements; Young Adult; Zinc

2012
Arsenic levels in drinking water and mortality of liver cancer in Taiwan.
    Journal of hazardous materials, 2013, Nov-15, Volume: 262

    Topics: Adolescent; Adult; Aged; Arsenic; Child; Child, Preschool; Cities; Dose-Response Relationship, Drug; Drinking Water; Environmental Exposure; Environmental Monitoring; Female; Humans; Infant; Infant, Newborn; Liver; Liver Neoplasms; Male; Middle Aged; Multivariate Analysis; Registries; Regression Analysis; Risk Assessment; Software; Taiwan; Water Pollutants, Chemical; Young Adult

2013
Pathology related to chronic arsenic exposure.
    Environmental health perspectives, 2002, Volume: 110 Suppl 5

    Topics: Adolescent; Adult; Aged; Arsenic; Carcinoma, Hepatocellular; Carcinoma, Squamous Cell; Environmental Exposure; Female; Hemangiosarcoma; Humans; Liver Cirrhosis; Liver Neoplasms; Male; Middle Aged; Skin Diseases; Water Supply

2002
[Arsenic, liver and tumors; hemangioendothelioma].
    Zeitschrift fur Krebsforschung, 1957, Volume: 61, Issue:5

    Topics: Arsenic; Arsenic Poisoning; Hemangioendothelioma; Hemangiosarcoma; Humans; Liver Cirrhosis; Liver Neoplasms

1957
Toxicogenomic analysis of aberrant gene expression in liver tumors and nontumorous livers of adult mice exposed in utero to inorganic arsenic.
    Toxicological sciences : an official journal of the Society of Toxicology, 2004, Volume: 77, Issue:2

    Topics: Animals; Arsenic; Carcinogens; Carcinoma, Hepatocellular; Drinking; Female; Gene Expression; Gene Expression Profiling; Liver Neoplasms; Male; Mice; Mice, Inbred C3H; Oligonucleotide Array Sequence Analysis; Pregnancy; Prenatal Exposure Delayed Effects; Reverse Transcriptase Polymerase Chain Reaction; Water; Water Pollutants, Chemical

2004
Cancer burden from arsenic in drinking water in Bangladesh.
    American journal of public health, 2004, Volume: 94, Issue:5

    Topics: Age Factors; Arsenic; Female; Humans; Liver Neoplasms; Lung Neoplasms; Male; Population Surveillance; Prospective Studies; Risk Factors; Sex Factors; Taiwan; Urinary Bladder Neoplasms; Water Pollutants, Chemical

2004
Deprenyl, a therapeutic agent for Parkinson's disease, inhibits arsenic toxicity potentiated by GSH depletion via inhibition of JNK activation.
    Journal of toxicology and environmental health. Part A, 2004, Volume: 67, Issue:23-24

    Topics: Animals; Antiparkinson Agents; Arsenic; Carcinoma, Hepatocellular; Cell Culture Techniques; Drug Interactions; Glutathione; JNK Mitogen-Activated Protein Kinases; Liver Neoplasms; MAP Kinase Kinase 4; Mitochondria; Mitogen-Activated Protein Kinase Kinases; Rats; Selegiline; Tumor Cells, Cultured

2004
Simultaneous determination of arsenic and selenium in biological samples by HG-AFS.
    Analytical and bioanalytical chemistry, 2005, Volume: 382, Issue:4

    Topics: Animals; Arsenic; Borohydrides; Cattle; Liver Neoplasms; Rabbits; Selenium; Sensitivity and Specificity; Spectrometry, Fluorescence; Spectrophotometry, Atomic; Swine

2005
Transplacental arsenic plus postnatal 12-O-teradecanoyl phorbol-13-acetate exposures associated with hepatocarcinogenesis induce similar aberrant gene expression patterns in male and female mouse liver.
    Toxicology and applied pharmacology, 2006, Jun-15, Volume: 213, Issue:3

    Topics: Administration, Topical; Animals; Arsenic; Female; Gene Expression Profiling; Gene Expression Regulation; Liver; Liver Neoplasms; Male; Maternal-Fetal Exchange; Mice; Mice, Inbred C3H; Oligonucleotide Array Sequence Analysis; Pregnancy; Prenatal Exposure Delayed Effects; Tetradecanoylphorbol Acetate

2006
Global gene expression associated with hepatocarcinogenesis in adult male mice induced by in utero arsenic exposure.
    Environmental health perspectives, 2006, Volume: 114, Issue:3

    Topics: Animals; Arsenic; Carcinoma, Hepatocellular; Female; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Liver; Liver Neoplasms; Male; Maternal-Fetal Exchange; Mice; Mice, Inbred C3H; Pregnancy; Prenatal Exposure Delayed Effects; Toxicogenetics

2006
Enhanced urinary bladder and liver carcinogenesis in male CD1 mice exposed to transplacental inorganic arsenic and postnatal diethylstilbestrol or tamoxifen.
    Toxicology and applied pharmacology, 2006, Sep-15, Volume: 215, Issue:3

    Topics: Animals; Arsenic; Diethylstilbestrol; Drug Synergism; Estrogen Receptor alpha; Estrogens, Non-Steroidal; Female; Liver Neoplasms; Male; Maternal-Fetal Exchange; Mice; Mice, Inbred Strains; Pregnancy; Prenatal Exposure Delayed Effects; Selective Estrogen Receptor Modulators; Tamoxifen; Urinary Bladder Neoplasms

2006
Phenotypic anchoring of arsenic and cadmium toxicity in three hepatic-related cell systems reveals compound- and cell-specific selective up-regulation of stress protein expression: implications for fingerprint profiling of cytotoxicity.
    Chemico-biological interactions, 2006, Jul-10, Volume: 161, Issue:3

    Topics: Animals; Arsenic; Cadmium; Cell Survival; Cells, Cultured; DNA Fingerprinting; Heat-Shock Proteins; Hepatocytes; Humans; Liver Neoplasms; Male; Phenotype; Rats; Rats, Wistar; Up-Regulation

2006
Further studies on aberrant gene expression associated with arsenic-induced malignant transformation in rat liver TRL1215 cells.
    Toxicology and applied pharmacology, 2006, Nov-01, Volume: 216, Issue:3

    Topics: Animals; Arsenic; Arsenites; Azacitidine; Blotting, Western; Carcinogens; Cell Cycle; Cell Line; Cell Transformation, Neoplastic; Dealkylation; Decitabine; DNA, Neoplasm; Gene Expression; Gene Expression Regulation, Developmental; Gene Expression Regulation, Neoplastic; Growth; Intercellular Signaling Peptides and Proteins; Liver Neoplasms; Rats; Reverse Transcriptase Polymerase Chain Reaction; Stress, Physiological

2006
Differential protection and transactivation of P53, P21, Bcl2, PCNA, cyclin G, and MDM2 genes in rat liver and the HepG2 cell line upon exposure to pifithrin.
    Biomedical sciences instrumentation, 2007, Volume: 43

    Topics: Animals; Arsenic; Benzothiazoles; Cadmium; Cell Line, Tumor; Cells, Cultured; Cytoprotection; DNA Damage; DNA Repair; Dose-Response Relationship, Drug; Drug Combinations; Gene Expression Regulation; Hepatoblastoma; Hepatocytes; Humans; Lethal Dose 50; Liver Neoplasms; Male; Neoplasm Proteins; Rats; Rats, Wistar; Toluene; Tumor Suppressor Protein p53

2007
[The determination of the level of arsenic in human liver tissue under physiological and pathological conditions].
    Frankfurter Zeitschrift fur Pathologie, 1967, Volume: 76, Issue:2

    Topics: Arsenic; Colorimetry; Fatty Liver; Humans; In Vitro Techniques; Liver; Liver Cirrhosis; Liver Neoplasms

1967
Hepatic angiosarcoma and bronchioloalveolar carcinoma induced by Fowler's solution.
    JAMA, 1984, Dec-28, Volume: 252, Issue:24

    Topics: Adenocarcinoma, Bronchiolo-Alveolar; Aged; Arsenic; Arsenites; Dermatitis Herpetiformis; Hemangiosarcoma; Humans; Liver Neoplasms; Lung Neoplasms; Male; Neoplasms, Multiple Primary; Potassium; Potassium Compounds; Smoking

1984
New approaches to the neutron activation analysis in biomedical sciences.
    Acta Universitatis Carolinae. Medica. Monographia, 1980, Volume: 95

    Topics: Activation Analysis; Animals; Arsenic; Bone and Bones; Copper; Gold; Gold Colloid, Radioactive; Humans; Kidney; Liver; Liver Neoplasms; Mercury; Muscles; Neutron Activation Analysis; Phosphorus; Potassium; Rats; Sodium

1980
[Angiosarcoma of the liver after short-term arsenic therapy].
    Morphologiai es igazsagugyi orvosi szemle, 1984, Volume: 24, Issue:2

    Topics: Arsenic; Dose-Response Relationship, Drug; Hemangiosarcoma; Humans; Liver Neoplasms; Male; Middle Aged; Psoriasis

1984
Angiosarcoma of the liver: a growing problem?
    British medical journal (Clinical research ed.), 1981, Feb-14, Volume: 282, Issue:6263

    Topics: Animals; Arsenic; Hemangiosarcoma; Humans; Liver Neoplasms; Neoplasms, Radiation-Induced; Occupational Diseases; Polyvinyl Chloride; Rats; Thorium Dioxide; United Kingdom

1981
The consequences of chronic arsenic poisoning among Moselle wine growers. Pathoanatomical investigations of post-mortem examinations performed between 1960 and 1977.
    Journal of cancer research and clinical oncology, 1983, Volume: 105, Issue:2

    Topics: Arsenic; Arsenic Poisoning; Autopsy; Data Collection; Germany, West; Humans; Insecticides; Liver Cirrhosis; Liver Neoplasms; Lung Neoplasms; Neoplasms, Multiple Primary; Occupational Diseases; Skin Neoplasms; Wine

1983
Arsenic-related hepatic angiosarcoma.
    American journal of industrial medicine, 1981, Volume: 2, Issue:1

    Topics: Adult; Arsenic; Arsenites; Asthma; Environmental Exposure; Female; Hemangiosarcoma; Humans; Liver Neoplasms; Male; Middle Aged; Potassium; Potassium Compounds; United States; Vinyl Chloride

1981
Epidemiology of angiosarcoma of liver in New York State.
    New York state journal of medicine, 1981, Volume: 81, Issue:6

    Topics: Adolescent; Adult; Aged; Arsenic; Environmental Exposure; Female; Hemangiosarcoma; Humans; Infant; Infant, Newborn; Liver Neoplasms; Male; Middle Aged; New York; Registries; Thorium Dioxide; Vinyl Chloride

1981
Review of four cases of childhood hepatic angiosarcoma--elevated environmental arsenic exposure in one case.
    Cancer, 1981, Jan-15, Volume: 47, Issue:2

    Topics: Arsenic; Carcinogens, Environmental; Child, Preschool; Environmental Exposure; Female; Hemangioendothelioma; Hemangiosarcoma; Humans; Infant; Liver Neoplasms; Risk

1981
Tumors in patients with angiosarcoma of the liver.
    Annals of internal medicine, 1981, Volume: 95, Issue:2

    Topics: Adult; Aged; Arsenic; Female; Hemangiosarcoma; Humans; Liver Neoplasms; Male; Middle Aged; Neoplasms, Multiple Primary; Thorium Dioxide; Vinyl Chloride

1981
Arsenic dose in patients with cutaneous carcinomata and hepatic hemangio-endothelioma after environmental and occupational exposure.
    Archives of toxicology, 1981, Volume: 47, Issue:2

    Topics: Adult; Arsenic; Female; Hemangioendothelioma; Humans; Liver Neoplasms; Male; Middle Aged; Occupational Diseases; Regression Analysis; Skin Neoplasms; Water Pollutants; Water Pollutants, Chemical; Water Supply

1981
Significance of exposure assessment to analysis of cancer risk from inorganic arsenic in drinking water in Taiwan.
    Risk analysis : an official publication of the Society for Risk Analysis, 1995, Volume: 15, Issue:4

    Topics: Adult; Arsenic; Carcinogens; Dose-Response Relationship, Drug; Environmental Exposure; Female; Humans; Liver Neoplasms; Lung Neoplasms; Male; Neoplasms; Risk Assessment; Taiwan; Urinary Bladder Neoplasms; Water Pollution; Water Supply

1995
[A study on the relationship between drinking water with high arsenic content and incidence of malignant tumour in Heihe Village, western part of Huhehot, Inner Mongolia].
    Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi, 1995, Volume: 16, Issue:5

    Topics: Arsenic; China; Humans; Incidence; Liver Neoplasms; Longitudinal Studies; Lung Neoplasms; Prospective Studies; Risk Factors; Urinary Bladder Neoplasms; Water Pollutants, Chemical; Water Supply

1995
Lung and kidney cancer mortality associated with arsenic in drinking water in Córdoba, Argentina.
    International journal of epidemiology, 1998, Volume: 27, Issue:4

    Topics: Argentina; Arsenic; Environmental Exposure; Female; Humans; Kidney Neoplasms; Liver Neoplasms; Lung Neoplasms; Male; Skin Neoplasms; Stomach Neoplasms; Urinary Bladder Neoplasms; Water Supply

1998
Risk of internal cancers from arsenic in drinking water.
    Environmental health perspectives, 2000, Volume: 108, Issue:7

    Topics: Adult; Aged; Aged, 80 and over; Arsenic; Diet; Female; Humans; Incidence; Life Expectancy; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Models, Statistical; Public Health; Risk Assessment; Urinary Bladder Neoplasms; Water Supply

2000
Application of cDNA microarray to the study of arsenic-induced liver diseases in the population of Guizhou, China.
    Toxicological sciences : an official journal of the Society of Toxicology, 2001, Volume: 59, Issue:1

    Topics: Arsenic; Arsenic Poisoning; Biopsy, Needle; Carcinogens, Environmental; Carcinoma, Hepatocellular; China; DNA, Complementary; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Image Processing, Computer-Assisted; Liver; Liver Neoplasms; Necrosis; Oligonucleotide Array Sequence Analysis; RNA

2001
A touch of poison.
    Scientific American, 2001, Volume: 284, Issue:6

    Topics: Argentina; Arsenic; Chile; Humans; Liver Neoplasms; Lung Neoplasms; Mining; Skin Neoplasms; Taiwan; United States; United States Environmental Protection Agency; Urinary Bladder Neoplasms; Water Pollutants, Chemical; Water Supply

2001
[Liver tumors caused by environmental factors].
    Der Internist, 1977, Volume: 18, Issue:4

    Topics: Anabolic Agents; Animals; Arsenic; Carcinoma, Hepatocellular; Contraceptives, Oral; Environmental Exposure; Environmental Health; Female; Hemangiosarcoma; Humans; Liver Cirrhosis; Liver Neoplasms; Male; Neoplasms, Experimental; Occupational Diseases; Precancerous Conditions; Rodentia; Thorium Dioxide; Vinyl Chloride

1977
Liver disease associated with chronic arsenic ingestion.
    Australian and New Zealand journal of medicine, 1979, Volume: 9, Issue:3

    Topics: Arsenic; Carcinoma, Basal Cell; Carcinoma, Hepatocellular; Humans; Keratosis; Liver Cirrhosis; Liver Neoplasms; Male; Middle Aged; Skin Neoplasms

1979
Development of hepatic angiosarcoma in man induced by vinyl chloride, thorotrast, and arsenic. Comparison with cases of unknown etiology.
    The American journal of pathology, 1978, Volume: 92, Issue:2

    Topics: Adolescent; Adult; Aged; Arsenic; Child, Preschool; Female; Hemangiosarcoma; Humans; Hyperplasia; Liver; Liver Neoplasms; Male; Middle Aged; Retrospective Studies; Thorium Dioxide; Vinyl Chloride; Vinyl Compounds

1978
Angiosarcoma of the liver associated with Fowler's solution (potassium arsenite).
    Gastroenterology, 1975, Volume: 68, Issue:6

    Topics: Adult; Arsenic; Arsenites; Cobalt Radioisotopes; Hemangiosarcoma; Humans; Liver; Liver Neoplasms; Male; Potassium; Potassium Compounds; Psoriasis

1975
Cancer potential in liver, lung, bladder and kidney due to ingested inorganic arsenic in drinking water.
    British journal of cancer, 1992, Volume: 66, Issue:5

    Topics: Adult; Aged; Arsenic; Female; Humans; Kidney Neoplasms; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Models, Statistical; Organ Specificity; Risk Factors; Sex Factors; Taiwan; Urinary Bladder Neoplasms; Water Supply

1992
Activation of heme oxygenase and heat shock protein 70 genes by stress in human hepatoma cells.
    Biochemical and biophysical research communications, 1990, Feb-14, Volume: 166, Issue:3

    Topics: Arsenic; Arsenites; Cadmium; Cadmium Chloride; Carcinoma, Hepatocellular; Cell Line; Gene Expression Regulation; Heat-Shock Proteins; Heme; Heme Oxygenase (Decyclizing); Hot Temperature; Humans; Iodoacetamide; Kinetics; Liver Neoplasms; Mixed Function Oxygenases; RNA, Messenger; Sodium Compounds; Transcription, Genetic; Tumor Cells, Cultured

1990
Arsenic and non-cirrhotic portal hypertension. A report of eight cases.
    Journal of hepatology, 1990, Volume: 11, Issue:1

    Topics: Adult; Arsenic; Biopsy; Female; Follow-Up Studies; Humans; Hypertension, Portal; Liver; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Psoriasis; Skin Neoplasms

1990
[Hepato-splenic hemangiosarcoma: presentation of a clinical case].
    Revista espanola de las enfermedades del aparato digestivo, 1989, Volume: 76, Issue:3

    Topics: Aged; Agricultural Workers' Diseases; Arsenic; Carcinoma, Hepatocellular; Colonic Neoplasms; Hemangiosarcoma; Humans; Liver Neoplasms; Male; Mesentery; Neoplasms, Multiple Primary; Omentum; Peritoneal Neoplasms; Splenic Neoplasms; Uruguay

1989
[Angiosarcoma of the liver following brief arsenic therapy].
    Zentralblatt fur allgemeine Pathologie u. pathologische Anatomie, 1985, Volume: 130, Issue:6

    Topics: Arsenic; Hemangiosarcoma; Humans; Liver; Liver Neoplasms; Male; Middle Aged; Psoriasis

1985
ATP level and control of glycolysis in Novikoff ascites-hepatoma cells.
    Enzymologia, 1969, Volume: 36, Issue:4

    Topics: Adenine Nucleotides; Adenosine Triphosphate; Animals; Arsenic; Ascites; Carcinoma, Hepatocellular; Dinitrophenols; Glucose; Glycolysis; Hexosephosphates; Iodoacetates; Lactates; Liver Neoplasms; Neoplasms, Experimental; Rats; Stimulation, Chemical

1969
Effect of feeding amino azo dyes on mitochondrial swelling and contraction. Kinetic evidence for deletion of membrane regulatory sites.
    Cancer research, 1969, Volume: 29, Issue:6

    Topics: Adenosine Triphosphate; Animals; Arsenic; Carcinoma, Hepatocellular; Cell Membrane; Chloromercuribenzoates; Kinetics; Liver Neoplasms; Male; Methods; Mitochondria, Liver; Neoplasms, Experimental; p-Dimethylaminoazobenzene; Phlorhizin; Phosphates; Potassium Chloride; Proteins; Rats; Saponins; Sucrose; Thyroxine; Time Factors

1969
Studies on cell adhesion. II. Adhesion of cells to surfaces of diverse chemical composition and inhibition of adhesion by sulfhydryl binding reagents.
    Archives of biochemistry and biophysics, 1972, Volume: 153, Issue:1

    Topics: Agar; Alloys; Aluminum; Animals; Arsenic; Carcinoma, Hepatocellular; Cell Adhesion; Cell Division; Cell Line; Densitometry; Ethylmaleimide; Glass; Iodoacetates; Kinetics; Liver Neoplasms; Mercuribenzoates; Mercury; Polyethylenes; Polymers; Polytetrafluoroethylene; Rats; Silicones

1972
The determination of arylsulfatases in biological fluids.
    Clinica chimica acta; international journal of clinical chemistry, 1970, Volume: 29, Issue:3

    Topics: 1-Propanol; Alcoholism; Arsenic; Coumarins; Drug Stability; Fluorometry; Humans; Hydrogen-Ion Concentration; Kinetics; Liver Neoplasms; Methods; Pancreatitis; Poisoning; Saliva; Sulfatases

1970
Hemangioendothelial sarcoma of liver from chronic arsenic intoxication by Fowler's solution.
    Cancer, 1968, Volume: 21, Issue:3

    Topics: Arsenic; Carcinogens; Hemangiosarcoma; Humans; Liver Neoplasms; Male; Middle Aged; Psoriasis

1968
Life term studies on the effect of trace elements on spontaneous tumors in mice and rats.
    Cancer research, 1969, Volume: 29, Issue:4

    Topics: Adrenal Gland Neoplasms; Animals; Antimony; Arsenic; Cadmium; Chromates; Diet; Female; Fluorine; Germanium; Lead; Liver Neoplasms; Lung Neoplasms; Male; Mammary Neoplasms, Experimental; Neoplasms, Experimental; Niobium; Rats; Time Factors; Tin; Trace Elements; Zirconium

1969